Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH7 ATRX ACTB DDX6 DHX15 SMPDL3A ATP2C2 MLH1 ATP11A ATP13A4 ABCB5 RNF213 NLRP1 CHD7 FANCM DNAH7 NLRP3 RAD50 ABCB11 HSP90AB2P DNAH11	3.11e-06	441	297	21	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	TMEM30B MYH7 ATRX ACTB DDX6 MYO5C DHX15 SMPDL3A ATP2C2 MLH1 ATP11A ATP13A4 MYH7B ABCB5 RNF213 NLRP1 CHD7 FANCM DNAH7 NLRP3 RAD50 DNAI2 ABCB11 HSP90AB2P DNAH11	5.80e-06	614	297	25	GO:0140657
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	ACTB ACTG1 POTEKP POTEI	1.46e-05	11	297	4	GO:0098973
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ABL2 PDGFRL MARK1 NEK10 PFKFB1 PFKFB4 ACVR1B PAK6 CHKA NEK1 BRAF RPS6KA6 SIK2 PIP5K1B PPIP5K2 DNTT CDC42BPG PARP11 TENT4B TENT4A DDR2 POLR2H DGKZ LRRK1 TEC CDC42BPB GUK1 LYN TSSK1B ULK2 NEK11	2.87e-05	938	297	31	GO:0016772
GeneOntologyMolecularFunction	glutamate receptor activity	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.34e-05	27	297	5	GO:0008066
GeneOntologyMolecularFunction	kinase activity	ABL2 PDGFRL MARK1 NEK10 PFKFB1 PFKFB4 ACVR1B PAK6 CHKA NEK1 BRAF RPS6KA6 SIK2 PIP5K1B PPIP5K2 CDC42BPG DDR2 DGKZ LRRK1 TEC CDC42BPB GUK1 LYN TSSK1B ULK2 NEK11	8.10e-05	764	297	26	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ABL2 PDGFRL MARK1 NEK10 PFKFB1 PFKFB4 ACVR1B PAK6 CHKA NEK1 BRAF RPS6KA6 SIK2 PIP5K1B CDC42BPG DDR2 DGKZ LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	1.66e-04	709	297	24	GO:0016773
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	2.20e-04	2	297	2	GO:0016639
GeneOntologyMolecularFunction	acetyl-CoA carboxylase activity	ACACA ACACB	2.20e-04	2	297	2	GO:0003989
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	2.20e-04	2	297	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	2.20e-04	2	297	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	2.20e-04	2	297	2	GO:0004354
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC10A4 PKD1L1 SLC28A3 SLC30A2 KCNC3 SCN3A ATP2C2 SCN8A TRPM8 KCNT1 SLC6A18 ATP13A4 CACHD1 GRIN2C GRIN2D LRRC52 SLC5A11 CACNA2D3	2.25e-04	465	297	18	GO:0046873
GeneOntologyMolecularFunction	cholinesterase activity	ACHE CHKA	6.55e-04	3	297	2	GO:0004104
GeneOntologyMolecularFunction	protein kinase activity	ABL2 PDGFRL MARK1 NEK10 ACVR1B PAK6 CHKA NEK1 BRAF RPS6KA6 SIK2 CDC42BPG DDR2 LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	7.01e-04	600	297	20	GO:0004672
GeneOntologyCellularComponent	glutamatergic synapse	ABL2 PSEN2 MARK1 ACTB BTBD9 PDE10A SORT1 AP2S1 BRAF KCNC3 SCN8A GPC4 ADGRL2 CNTN1 DRP2 DOCK10 ARFGEF2 DGKZ GRIA4 GRID1 RPSA GRIN2C GRIN2D GPC6 GRM8 IL1RAPL1 TENM4 LYN	1.91e-05	817	299	28	GO:0098978
Domain	TPR_8	SPAG1 NCF2 GTF3C3 XAB2 IFIT1B TTC13 CFAP70 CDC27	1.69e-06	53	295	8	PF13181
Domain	GLYPICAN	GPC3 GPC4 GPC6	7.53e-05	6	295	3	PS01207
Domain	Glypican	GPC3 GPC4 GPC6	7.53e-05	6	295	3	IPR001863
Domain	Glypican	GPC3 GPC4 GPC6	7.53e-05	6	295	3	PF01153
Domain	Glypican_CS	GPC3 GPC4 GPC6	7.53e-05	6	295	3	IPR019803
Domain	Glu/Gly-bd	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	IPR019594
Domain	Lig_chan-Glu_bd	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	SM00918
Domain	Iontro_rcpt	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	IPR001320
Domain	PBPe	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	SM00079
Domain	Lig_chan-Glu_bd	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	PF10613
Domain	Iono_rcpt_met	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	IPR001508
Domain	Lig_chan	GRIA4 GRID1 GRIN2C GRIN2D	1.57e-04	18	295	4	PF00060
Domain	Myosin-like_IQ_dom	MYH7 MYO5C ASPM MYH7B	1.96e-04	19	295	4	IPR027401
Domain	-	MYH7 MYO5C ASPM MYH7B	1.96e-04	19	295	4	4.10.270.10
Domain	TPR	SPAG1 NCF2 GTF3C3 XAB2 TTC8 IFIT1B TTC13 CFAP70 CDC27	2.12e-04	129	295	9	SM00028
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	2.49e-04	2	295	2	PF02812
Domain	ELFV_dehydrog	GLUD1 GLUD2	2.49e-04	2	295	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	2.49e-04	2	295	2	IPR033922
Domain	ELFV_dehydrog	GLUD1 GLUD2	2.49e-04	2	295	2	SM00839
Domain	ACC_central	ACACA ACACB	2.49e-04	2	295	2	PF08326
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	2.49e-04	2	295	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	2.49e-04	2	295	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	2.49e-04	2	295	2	IPR006095
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	2.49e-04	2	295	2	PS00074
Domain	AcCoA_COase_cen	ACACA ACACB	2.49e-04	2	295	2	IPR013537
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	2.49e-04	2	295	2	IPR033524
Domain	TPR_repeat	SPAG1 NCF2 GTF3C3 XAB2 TTC8 IFIT1B TTC13 CFAP70 CDC27	2.67e-04	133	295	9	IPR019734
Domain	ANF_lig-bd_rcpt	GRIA4 GRID1 GRIN2C GRIN2D GRM8	2.74e-04	37	295	5	IPR001828
Domain	ANF_receptor	GRIA4 GRID1 GRIN2C GRIN2D GRM8	2.74e-04	37	295	5	PF01094
Domain	Peripla_BP_I	GRIA4 GRID1 GRIN2C GRIN2D GRM8	3.52e-04	39	295	5	IPR028082
Domain	Quino_amine_DH_bsu	FSTL5 LRRK1 NBAS WDR6	3.56e-04	22	295	4	IPR011044
Domain	NTP_transf_2	DNTT TENT4B TENT4A	5.86e-04	11	295	3	PF01909
Domain	DOCK	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	IPR026791
Domain	DOCK_C	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	IPR010703
Domain	DOCK-C2	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	PF14429
Domain	Polymerase_NTP_transf_dom	DNTT TENT4B TENT4A	5.86e-04	11	295	3	IPR002934
Domain	DHR-1_domain	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	IPR027007
Domain	DHR_2	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	PS51651
Domain	DHR_1	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	PS51650
Domain	DHR-2	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	PF06920
Domain	DHR-2	DOCK6 DOCK3 DOCK10	5.86e-04	11	295	3	IPR027357
Domain	TPR-contain_dom	SPAG1 NCF2 GTF3C3 XAB2 TTC8 IFIT1B TTC13 CFAP70 CDC27	6.44e-04	150	295	9	IPR013026
Domain	ETS_PEA3_N	ETV1 ETV4	7.38e-04	3	295	2	IPR006715
Domain	ETS_PEA3_N	ETV1 ETV4	7.38e-04	3	295	2	PF04621
Domain	Prot_kinase_dom	ABL2 MARK1 NEK10 ACVR1B PAK6 NEK1 BRAF RPS6KA6 SIK2 CDC42BPG DDR2 LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	8.20e-04	489	295	18	IPR000719
Domain	PROTEIN_KINASE_DOM	ABL2 MARK1 NEK10 ACVR1B PAK6 NEK1 BRAF RPS6KA6 SIK2 CDC42BPG DDR2 LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	8.99e-04	493	295	18	PS50011
Domain	Kinase-like_dom	ABL2 MARK1 NEK10 ACVR1B PAK6 CHKA NEK1 BRAF RPS6KA6 SIK2 CDC42BPG DDR2 LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	1.05e-03	542	295	19	IPR011009
Domain	PROTEIN_KINASE_ATP	ABL2 MARK1 NEK10 ACVR1B PAK6 NEK1 BRAF RPS6KA6 SIK2 CDC42BPG LRRK1 TEC CDC42BPB LYN TSSK1B ULK2 NEK11	1.06e-03	459	295	17	PS00107
Domain	Protein_kinase_ATP_BS	ABL2 MARK1 NEK10 ACVR1B PAK6 NEK1 BRAF RPS6KA6 SIK2 CDC42BPG TEC CDC42BPB LYN TSSK1B ULK2	1.08e-03	379	295	15	IPR017441
Domain	TPR-like_helical_dom	SPAG1 NCF2 GTF3C3 XAB2 TTC8 IFIT1B TTC13 CFAP70 SPATA16 CSTF3 CDC27	1.24e-03	233	295	11	IPR011990
Domain	Actin	ACTB ACTG1 ACTR6 POTEI	1.37e-03	31	295	4	IPR004000
Domain	Actin	ACTB ACTG1 ACTR6 POTEI	1.37e-03	31	295	4	PF00022
Domain	ACTIN	ACTB ACTG1 ACTR6 POTEI	1.37e-03	31	295	4	SM00268
Domain	Carboxyl_trans	ACACA ACACB	1.46e-03	4	295	2	PF01039
Domain	6Phosfructo_kin	PFKFB1 PFKFB4	1.46e-03	4	295	2	IPR013079
Domain	COA_CT_CTER	ACACA ACACB	1.46e-03	4	295	2	PS50989
Domain	COA_CT_NTER	ACACA ACACB	1.46e-03	4	295	2	PS50980
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPG CDC42BPB	1.46e-03	4	295	2	PD011252
Domain	6Pfruct_kin	PFKFB1 PFKFB4	1.46e-03	4	295	2	IPR003094
Domain	6PF2K	PFKFB1 PFKFB4	1.46e-03	4	295	2	PF01591
Domain	Carboxyl_trans	ACACA ACACB	1.46e-03	4	295	2	IPR000022
Domain	Neurofascin/L1/NrCAM_C	CHL1 NFASC	1.46e-03	4	295	2	IPR026966
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPG CDC42BPB	1.46e-03	4	295	2	IPR014930
Domain	Bravo_FIGEY	CHL1 NFASC	1.46e-03	4	295	2	PF13882
Domain	COA_CT_N	ACACA ACACB	1.46e-03	4	295	2	IPR011762
Domain	COA_CT_C	ACACA ACACB	1.46e-03	4	295	2	IPR011763
Domain	DMPK_coil	CDC42BPG CDC42BPB	1.46e-03	4	295	2	PF08826
Domain	Myosin_N	MYH7 MYO5C MYH7B	1.54e-03	15	295	3	IPR004009
Domain	Myosin_N	MYH7 MYO5C MYH7B	1.54e-03	15	295	3	PF02736
Domain	-	SPAG1 NCF2 GTF3C3 XAB2 TTC8 IFIT1B TTC13 CFAP70 SPATA16 CSTF3	1.73e-03	207	295	10	1.25.40.10
Domain	IQ	MYH7 MYO5C SCN3A SCN8A ASPM MYH7B	1.78e-03	81	295	6	SM00015
Domain	S_TKc	MARK1 NEK10 ACVR1B PAK6 NEK1 BRAF RPS6KA6 SIK2 CDC42BPG LRRK1 CDC42BPB TSSK1B ULK2 NEK11	1.80e-03	359	295	14	SM00220
Domain	Actin_CS	ACTB ACTG1 POTEI	1.88e-03	16	295	3	IPR004001
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCSK5 RIN3 ACACA MYCBP2 EXOSC8 DYSF BIRC6 AP2S1 NF2 RBM19 SCN8A DOCK6 DOCK3 KIAA0930 PPP1R3B AKNA ARFGEF2 GRID1 RPSA CFAP43 LRRK1 PPARA GRIN2D CDC42BPB ANO8 KMT2D FANCI PAXIP1 SYVN1 ULK2 EP300 CEP170B EVI5L	8.47e-10	1105	302	33	35748872
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	LUC7L3 MYCBP2 MARK1 ACTB LANCL1 EXOSC8 POGZ GTF3C3 XAB2 DDX6 DHX15 SLC25A3 AP2S1 CDC40 FEN1 GPC4 PCDH15 ALB PPIP5K2 DOCK6 FLG DPYSL2 POLR2H RPSA CHD7 GPC6 THOC5 PAXBP1 SEC24C UPF2 CSTF3 CNOT1	1.97e-09	1082	302	32	38697112
Pubmed	Defining the membrane proteome of NK cells.	PSEN2 MYCBP2 CNST ACOX1 ACTB ACTG1 BIRC6 ANKRD27 XAB2 DDX6 SLC25A3 NF2 RBM19 CNOT7 FEN1 MLH1 ATP11A GNPAT CNTRL DOCK10 AKNA ARFGEF2 RNF213 RPSA CPD RAD50 NBAS FANCI GIGYF2 SYVN1 CNOT1 HECA	1.21e-08	1168	302	32	19946888
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ACACA DYSF BIRC6 NF2 CNOT7 FEN1 GPC4 ASPM RPS6KA6 FGD1 CNTN1 FMO5 CHD7 FANCI PDE4DIP CNDP2 EP300	2.48e-08	363	302	17	14691545
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ACADM XAB2 SORT1 SLC25A3 WDR3 VPS52 CNOT7 COPS5 PCYOX1 GNPAT DPYSL2 CPD PAF1 RFX1 THOC5 RAD50 WDR6 FANCI CSTF3 CDC27 CNOT1	2.67e-08	560	302	21	35241646
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ACACA MYCBP2 ACTB LANCL1 POGZ SSBP1 BIRC6 ANKRD27 GTF3C3 DDX6 DHX15 BLMH SLC25A3 WDR3 AP2S1 CDC40 RBM19 FEN1 ASPM MLH1 SCFD1 DPYSL2 POLR2H DOCK10 RPSA CHD7 RAD50 CS SEC24C UPF2 WDR6 FANCI HSP90AB2P CDC27	3.38e-08	1353	302	34	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CABLES2 ACACA ATRX LUC7L3 MYCBP2 ETV1 NFASC PFKFB1 PFKFB4 BTBD9 PDE10A TTF1 TTC8 NF2 ARHGEF9 ATP11A DOCK6 COPS5 TSEN15 CDC42BPG FUT10 DPYSL2 DTNA RNF213 CPD PPARA CDC42BPB ANO8 PLEKHG4B EFNA5 CNDP2 CSTF3 CNOT1 EP300 CEP170B EVI5L	3.41e-08	1489	302	36	28611215
Pubmed	TRIM21 ameliorates hepatic glucose and lipid metabolic disorders in type 2 diabetes mellitus by ubiquitination of PEPCK1 and FASN.	MYCBP2 ACTB ACTG1 BLMH GLUD1 ARHGEF9 SCN8A TRPM8 ALB CFAP70 FLG AKNA DGKZ RPSA CS PDE4DIP OTUD7A	5.19e-08	382	302	17	37249651
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ACACA MYCBP2 ACTG1 POGZ GTF3C3 SLC25A3 NEK1 NF2 DPYSL2 DPYSL3 TEAD4 PAF1 CBL RFX1 RAD50 KMT2D WDR6 GIGYF2 CNOT1 EP300	9.22e-08	549	302	20	38280479
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	ACACA ACADM ACTB SSBP1 ARFIP2 EPB41L4A SQOR DHX15 SLC25A3 FAP AP2S1 IFIT1B GLUD1 GLUD2 MYDGF TMED2 MAIP1 SCFD1 PCYOX1 DPYSL2 DDR2 RNF213 CCDC80 RPSA CPD CBL RFX1 NT5DC3 IARS2 CS SEC24C NEIL3 EPDR1 EP300	1.76e-07	1451	302	34	30550785
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ACACA ACACB ACADM LUC7L3 ACTB TTF1 ANKRD27 XAB2 DDX6 DHX15 SLC25A3 WDR3 SLC25A32 VPS52 CDC40 GLUD1 FEN1 ALB SCFD1 PPIP5K2 POLR2H RPSA CHD7 PAF1 YARS1 CS PAXBP1 SEC24C UPF2 CNDP2 LYN CDC27	1.91e-07	1318	302	32	30463901
Pubmed	Functional proteomics mapping of a human signaling pathway.	ATRX MYCBP2 ACTB ACTG1 PSMD8 TTF1 ANKRD27 XAB2 ABRAXAS2 RBM19 COPS5 TSEN15 PPP1R3B ARFGEF2 RANBP6 NIBAN2 RFX1 KMT2D PDE4DIP PAXIP1	2.98e-07	591	302	20	15231748
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ACACA ATRX LUC7L3 ACTG1 LANCL1 PSMD8 POGZ SSBP1 GTF3C3 DDX6 DHX15 BLMH SLC25A3 WDR3 CDC40 RBM19 GLUD1 FEN1 SCFD1 PCYOX1 TENT4B ZNF280C RPSA YARS1 RAD50 IARS2 CS PAXBP1 WDR6 FANCI CSTF3 GIGYF2 CNOT1	3.53e-07	1425	302	33	30948266
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ACACA MYCBP2 DNAJC21 EXOSC8 POGZ DYSF XAB2 DDX6 DHX15 NF2 RBM19 DPYSL2 RPSA NIBAN2 PAF1 CDC42BPB THOC5 UPF2 WDR6 GIGYF2 CDC27 CNOT1	4.68e-07	724	302	22	36232890
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYCBP2 ACTB ACTG1 PSMD8 BIRC6 SORT1 BLMH ABRAXAS2 PTPN6 NF2 MTMR2 MLH1 ADGRL2 DPYSL3 DTNA ZNF280C RNF213 CPD CACHD1 NIBAN2 PAF1 CDC42BPB KMT2D FANCI TMF1 CSTF3 CNOT1	6.01e-07	1049	302	27	27880917
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	ACADM ACOX1 ACTB POTEKP SSBP1 SQOR DDX6 SLC25A3 GLUD1 FEN1 MLH1 MYDGF TMED2 ALB RAB32 PCYOX1 GNPAT DOCK10 NT5DC3 IARS2 CS SEC24C GUK1 NEK11	6.26e-07	859	302	24	31536960
Pubmed	Liver Glutamate Dehydrogenase Controls Whole-Body Energy Partitioning Through Amino Acid-Derived Gluconeogenesis and Ammonia Homeostasis.	GLUD1 GLUD2 ALB	6.48e-07	3	302	3	30002133
Pubmed	Glutamate delta-1 receptor regulates cocaine-induced plasticity in the nucleus accumbens.	GLUD1 GLUD2 GRID1	6.48e-07	3	302	3	30315226
Pubmed	SIK2 regulates fasting-induced PPARα activity and ketogenesis through p300.	SIK2 PPARA EP300	6.48e-07	3	302	3	26983400
Pubmed	Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes.	GLUD1 GLUD2 ALB	6.48e-07	3	302	3	37871770
Pubmed	Trans-Synaptic Signaling through the Glutamate Receptor Delta-1 Mediates Inhibitory Synapse Formation in Cortical Pyramidal Neurons.	GLUD1 GLUD2 GRID1	6.48e-07	3	302	3	31704028
Pubmed	Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.	GLUD1 GLUD2 GRID1	6.48e-07	3	302	3	23560106
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GAD2 MORN4 ACACA ACACB ACADM MYCBP2 CNST MARK1 SANBR BIRC6 AP2S1 GLUD1 GLUD2 DOCK3 DPYSL2 DTNA GRIA4 RPSA NT5DC3 CDC42BPB YARS1 ANO8 CS TENM4 PDE4DIP CNDP2 CNOT1 CEP170B	9.10e-07	1139	302	28	36417873
Pubmed	Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.	GAD2 ACHE GLUD1 GLUD2 GRIA4 GRIN2C GRIN2D GRM8 TPH2	9.74e-07	118	302	9	19156168
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	CABLES2 ABL2 ACACA ACACB MARK1 NF2 MTMR2 SCFD1 ADGRL2 DTNA CPD CACHD1 NIBAN2 CBL IARS2 WDR6	1.05e-06	421	302	16	36976175
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PCSK5 ACADM ATRX LUC7L3 DNAJC21 LANCL1 ANKRD27 XAB2 SLC25A32 CDC40 SIK2 MLH1 PPIP5K2 GNPAT CDC42BPG DOCK10 UPF2 WDR6 GIGYF2 ZBED1	1.30e-06	650	302	20	38777146
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACA ACACB ACVR1B ARFIP2 BIRC6 GTF3C3 WDR3 VPS52 NF2 RBM19 ALB SCFD1 ADGRL2 TENT4B CNTRL ARFGEF2 RNF213 CDC42BPB DNAH7 IARS2 SEC24C TMF1	1.50e-06	777	302	22	35844135
Pubmed	The sperm-associated antigen 6 interactome and its role in spermatogenesis.	LUC7L3 MYCBP2 SIDT1 PSMD8 BTBD9 TTC8 GPC4 COPS5 PCYOX1 DGKZ ANKEF1	1.53e-06	199	302	11	31146259
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CABLES2 MYH7 CLGN ABL2 ATRX MARK1 ACVR1B DDX6 NEK1 AP2S1 BRAF SIK2 COPS5 DTNA DDR2 POLR2H TEC CBL RAD50 EFNA5 PDE4DIP LYN CDC27 EP300	1.71e-06	910	302	24	36736316
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ABL2 ACACA ACACB PKD1L1 ACTG1 SSBP1 ARFIP2 WDR3 VPS52 MTMR2 PPIP5K2 DPYSL2 DPYSL3 CNTRL CPD DNAH7 RAD50 AKTIP IARS2 GIGYF2 LYN CNOT1 CEP170B	1.96e-06	853	302	23	28718761
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 MYCBP2 DYSF BIRC6 DHX15 GPC3 NF2 TRIM55 PPP1R3B DTNA PPARA PAF1 CDC42BPB AKTIP UPF2 PDE4DIP MYOM2	2.03e-06	497	302	17	23414517
Pubmed	A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.	MYCBP2 RBM19 CNOT7 WDR6 GIGYF2 CNOT1	2.18e-06	44	302	6	26471122
Pubmed	Human Antiviral Protein IFIX Suppresses Viral Gene Expression during Herpes Simplex Virus 1 (HSV-1) Infection and Is Counteracted by Virus-induced Proteasomal Degradation.	ATRX LUC7L3 GTF3C3 XAB2 GPC3 CDC40 GPC4 ZNF280C POLR2H PAF1 GPC6 GIGYF2	2.34e-06	251	302	12	28077445
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	TMEM30B PSEN2 SSBP1 ACVR1B TTF1 SORT1 AP2S1 ALG8 TMED2 MAIP1 SCFD1 DOCK6 RAB32 GNPAT KIAA0930 ARFGEF2 RANBP6 RNF213 CPD IARS2 CS FANCI PDE4DIP CNDP2 TMF1 CEP170B	2.40e-06	1061	302	26	33845483
Pubmed	Enriched expression of GluD1 in higher brain regions and its involvement in parallel fiber-interneuron synapse formation in the cerebellum.	GLUD1 GLUD2 GRID1	2.58e-06	4	302	3	24872547
Pubmed	Essential role of GluD1 in dendritic spine development and GluN2B to GluN2A NMDAR subunit switch in the cortex and hippocampus reveals ability of GluN2B inhibition in correcting hyperconnectivity.	GLUD1 GLUD2 GRID1	2.58e-06	4	302	3	25721396
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	CHL1 THSD4 PDGFRL DYSF ABCB5 GRIA4 PRPF18 SLC5A11 OTUD7A	2.82e-06	134	302	9	24324551
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MARK1 ACTB ACTG1 NFASC DDX6 DHX15 SLC25A3 AP2S1 GLUD1 GLUD2 MTMR2 ALB CNTN1 DPYSL2 DPYSL3 ARFGEF2 DGKZ RPSA NT5DC3 CDC42BPB YARS1 HAPLN1 CS TENM4 SEC24C UPF2 PDE4DIP CNOT1 CEP170B CACNA2D3 DNAH11	3.23e-06	1431	302	31	37142655
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	SPAG1 ACACA EXOSC8 PSMD8 SSBP1 GFUS XAB2 DHX15 BLMH SLC25A3 ABRAXAS2 RBM19 GLUD1 FEN1 MYDGF TMED2 SCFD1 PCYOX1 DPYSL2 RNF213 RPSA MUC5B NIBAN2 RAD50 IARS2 CS CSTF3 EPDR1 CDC27 CNOT1	3.64e-06	1367	302	30	32687490
Pubmed	NANOS2 interacts with the CCR4-NOT deadenylation complex and leads to suppression of specific RNAs.	DDX6 CNOT7 TDRD1 CNOT1	3.75e-06	13	302	4	20133598
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ACACA ACACB MYCBP2 POGZ BIRC6 GTF3C3 NEK1 CHD7 RFX1 RAD50 KMT2D WDR6 TMF1 GIGYF2 CNOT1	4.58e-06	418	302	15	34709266
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ACACA MYCBP2 POGZ TTF1 BIRC6 GTF3C3 XAB2 DHX15 WDR3 DPYSL2 RPSA CHD7 RAD50 IARS2 SEC24C WDR6 FANCI GIGYF2 CNOT1	5.36e-06	653	302	19	22586326
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	ACACA ACADM MYCBP2 ACTB ACTG1 PSMD8 SSBP1 BIRC6 GTF3C3 DDX6 DHX15 SLC25A3 ABRAXAS2 WDR3 AP2S1 GLUD1 GLUD2 MAIP1 COPS5 POLR2H RPSA PAF1 IARS2 WDR6 FANCI HSP90AB2P CDC27 CNOT1	5.93e-06	1257	302	28	37317656
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	ACTB ACTG1 POTEKP POTEI	7.05e-06	15	302	4	16824795
Pubmed	The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression.	POGZ GTF3C3 DHX15 ZNF280C POLR2H PAXBP1 CDC27	8.88e-06	84	302	7	26299517
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	LUC7L3 MYCBP2 ACTB SIDT1 ACTG1 LANCL1 SSBP1 GTF3C3 DDX6 DHX15 SLC25A3 FEN1 POLR2H RPSA CDC42BPB YARS1 IARS2 CS SEC24C CDC27 CNOT1	9.81e-06	809	302	21	32129710
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	ACACA ACACB MYCBP2 ACTB ACTG1 SSBP1 GTF3C3 DHX15 BLMH SLC25A3 WDR3 FEN1 ALB DPYSL2 RPSA YARS1 CS LYN	1.07e-05	624	302	18	33729478
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ACACA ACTB MYO5C SLC25A3 DOCK6 ARFGEF2 RPSA CDC42BPB NBAS CNOT1	1.21e-05	202	302	10	33005030
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYCBP2 ACTB ACTG1 POTEKP SLC25A3 CPD CDC42BPB UPF2 GIGYF2 CNOT1	1.21e-05	202	302	10	24639526
Pubmed	Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.	ACADM ACOX1 PPARA	1.27e-05	6	302	3	11018072
Pubmed	Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development.	GPC3 GPC4 GPC6	1.27e-05	6	302	3	23911103
Pubmed	K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.	GPC3 GPC4 GPC6	1.27e-05	6	302	3	7657705
Pubmed	An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways.	SCN3A SCN8A TRPM8	1.27e-05	6	302	3	23711479
Pubmed	Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle.	ACTB ACTG1 DTNA	1.27e-05	6	302	3	33002761
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ACACB LANCL1 SSBP1 CCDC85A TMED2 MAIP1 ATP13A4 DRP2 CHD7 CBL RFX1 DNAH7 IL1RAPL1 KMT2D PAXIP1 CNOT1 EP300 DNAH11	1.43e-05	638	302	18	31182584
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATRX LUC7L3 ACTB DDX6 FEN1 MLH1 USP48 COPS5 ARFGEF2 CHD7 NIBAN2 RAD50 SEC24C FANCI CSTF3 CDC27 CNOT1	1.60e-05	582	302	17	20467437
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	ACACA ACACB ATRX ACTB ACTG1 POGZ GTF3C3 XAB2 DHX15 MLH1 PAF1 SEC24C FANCI	1.70e-05	357	302	13	37059091
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	ACTB LANCL1 EXOSC8 PSMD8 POTEKP SSBP1 GTF3C3 DDX6 DHX15 BLMH SLC25A3 AP2S1 TMED2 MAIP1 SCFD1 COPS5 DTNA POLR2H RANBP6 RPSA PAF1 RAD50 CS SEC24C WDR6 CSTF3 HSP90AB2P CDC27	1.78e-05	1335	302	28	29229926
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATRX MYCBP2 DNAJC21 EXOSC8 PSMD8 SSBP1 GTF3C3 ABRAXAS2 WDR3 NF2 GLUD1 ASPM SIK2 TMED2 TTC13 SCFD1 ADGRL2 USP48 DTNA CPD NIBAN2 PAF1 CDC42BPB THOC5 NBAS IARS2 PAXBP1 SEC24C WDR6 CNDP2	1.84e-05	1487	302	30	33957083
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	LUC7L3 MYCBP2 NEK1 VPS52 CNOT7 GPC4 ASPM GNPAT DPYSL3 TENT4B POLR2H CS SYVN1 CDC27 CNOT1 EP300	2.04e-05	533	302	16	25544563
Pubmed	Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14.	GLUD1 GLUD2 GRID1	2.21e-05	7	302	3	10454512
Pubmed	A genome-wide association study of carotid atherosclerosis in HIV-infected men.	NF2 GRM8 THOC5	2.21e-05	7	302	3	20009918
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MYH7 ACACA ATRX LUC7L3 MYCBP2 PSMD8 PAK6 GTF3C3 DDX6 SORT1 ABRAXAS2 AP2S1 BRAF ASPM PIP5K1B PARP11 KIAA0930 POLR2H LRRK1 CDC42BPB YARS1 RAD50 AKTIP FANCI CSTF3 LYN CNOT1	2.41e-05	1284	302	27	17353931
Pubmed	PPARα-Target Gene Expression Requires TIS21/BTG2 Gene in Liver of the C57BL/6 Mice under Fasting Condition.	ACACA ACADM ACOX1 PPARA	2.42e-05	20	302	4	29385670
Pubmed	Identification of novel protein kinases expressed in the myocardium of the developing mouse heart.	MYH7 DDR2 TEC LYN	2.42e-05	20	302	4	7893599
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH7 SPAG1 ACACB ATRX ACTB SANBR ACTG1 DNAJC21 PSMD8 PDE10A SLC30A2 FAM186A GLUD1 GLUD2 GPC4 ASPM ATP11A PPIP5K2 FLG MYH7B DTNA ABCB5 CNTRL SLC44A2 GRIA4 PPARA MYOM2 POTEI CDC27	2.70e-05	1442	302	29	35575683
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MARK1 NFASC LANCL1 SSBP1 SQOR AP2S1 AMPD3 DTNA DGKZ GRIA4 CDC42BPB HAPLN1 TPH2 CEP170B	2.80e-05	430	302	14	32581705
Pubmed	A conserved acetylation switch enables pharmacological control of tubby-like protein stability.	LANCL1 BIRC6 GPC3 DOCK6 COPS5 GPC6 CBL PDE4DIP ZBED1 EP300	2.82e-05	223	302	10	33187986
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	LUC7L3 ACTB BIRC6 DHX15 SLC25A3 GLUD1 GLUD2 MTMR2 DPYSL2 POLR2H CSTF3	2.83e-05	271	302	11	25737280
Pubmed	New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.	MYH7 ETV1 ETV4 BRAF	2.97e-05	21	302	4	25035421
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	THSD4 DSCAML1 RBM19 PCDH15 USH2A NEK11 CACNA2D3	2.97e-05	101	302	7	18519826
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 NFASC BIRC6 DSCAML1 SIK2 DOCK10 CHD7 CDC42BPB TENM4 GIGYF2	3.05e-05	225	302	10	12168954
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ACACA ACADM ACTG1 PSMD8 ARFIP2 GFUS BIRC6 DHX15 BLMH ABRAXAS2 FEN1 MTMR2 USP48 COPS5 DPYSL2 DPYSL3 POLR2H ARFGEF2 RANBP6 RPSA NIBAN2 PAF1 YARS1 CS SEC24C FANCI CNDP2 HSP90AB2P CNOT1	3.17e-05	1455	302	29	22863883
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MARK1 BTBD9 BIRC6 CCDC85A ABRAXAS2 NEK1 ATP11A PCYOX1 DOCK3 KIAA0930 RNF213 FANCM CDC42BPB THOC5 ANO8	3.17e-05	493	302	15	15368895
Pubmed	Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.	ACTB ACTG1 TEC	3.52e-05	8	302	3	23260110
Pubmed	Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia.	GAD2 GRIA4 GRIN2D	3.52e-05	8	302	3	19125103
Pubmed	GluD1 is a signal transduction device disguised as an ionotropic receptor.	GLUD1 GLUD2 GRID1	3.52e-05	8	302	3	34135511
Pubmed	Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARα.	GLUD1 GLUD2 PPARA	3.52e-05	8	302	3	34857752
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATRX LUC7L3 ACTB ACTG1 POGZ XAB2 DHX15 SLC25A3 WDR3 RBM19 FEN1 ZNF280C RPSA CHD7 PAF1 FANCM RFX1 CS PAXBP1 FANCI CSTF3 GIGYF2	3.65e-05	954	302	22	36373674
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	GAD2 SCN8A GRIA4 GRIN2D GRM8	4.39e-05	45	302	5	25979088
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ACTB DNAJC21 EXOSC8 SSBP1 SQOR GTF3C3 XAB2 DDX6 DHX15 SLC25A3 WDR3 CDC40 RBM19 SRGAP1 GLUD1 FEN1 ALB TENT4B RPSA THOC5 YARS1 RAD50 IARS2 UPF2 WDR6 LYN	4.50e-05	1257	302	26	36526897
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MARK1 ACTB SIDT1 ACTG1 POTEKP SSBP1 DHX15 SLC25A3 FEN1 ADAMTS20 DSE TENT4B DDR2 NLRP1 RPSA	4.98e-05	513	302	15	25798074
Pubmed	Tudor domain containing 12 (TDRD12) is essential for secondary PIWI interacting RNA biogenesis in mice.	NAT2 CLGN MLH1 TDRD1	5.16e-05	24	302	4	24067652
Pubmed	Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly.	GAD2 CDC40 MAIP1 EVI5L	5.16e-05	24	302	4	33220177
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRIA4 GRIN2C GRIN2D GRM8	5.16e-05	24	302	4	35746896
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	LANCL1 POGZ SSBP1 WDR3 BRAF GPC4 ALB GNPAT NLRP1 CHD7 KMT2D PAXIP1 EP300	5.22e-05	398	302	13	35016035
Pubmed	Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling.	PTPN6 CBL LYN	5.24e-05	9	302	3	9045636
Pubmed	PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.	GRIN2C GRIN2D LYN	5.24e-05	9	302	3	9892651
Pubmed	Splicing and editing of ionotropic glutamate receptors: a comprehensive analysis based on human RNA-Seq data.	GRIA4 GRID1 GRIN2C	5.24e-05	9	302	3	34100982
Pubmed	In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.	ACADM ACOX1 ALB APOA2 PPARA	5.43e-05	47	302	5	16498401
Pubmed	Identification of kidney mesenchymal genes by a combination of microarray analysis and Sall1-GFP knockin mice.	ETV4 GPC6 EFNA5 TENM4 CEP170B	5.43e-05	47	302	5	15172686
Pubmed	Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.	PSEN2 ACTB ACTG1 CHKA BLMH PAXIP1 EVI5L	5.46e-05	111	302	7	21163940
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	MYH7 ACACA CNST DDX6 FANCI PDE4DIP EP300 DNAH11	5.86e-05	152	302	8	34299191
Pubmed	Interaction network of human early embryonic transcription factors.	ACACB POGZ SSBP1 SORT1 GLUD1 ALB CHD7 KMT2D WDR6 ZNF746 PAXIP1 EP300	6.56e-05	351	302	12	38297188
Pubmed	14-3-3ζ negatively regulates mitochondrial biogenesis in GBM residual cells.	ACTG1 LANCL1 POTEKP SQOR BLMH	6.66e-05	49	302	5	34825085
Pubmed	FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.	ACADM ACTB ACTG1 FEN1 COPS5 DPYSL2 RPSA CPD YARS1 CS	6.90e-05	248	302	10	32963011
Pubmed	Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain.	GPC3 GPC4 GPC6	7.44e-05	10	302	3	17107664
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ABL2 ACACA MYCBP2 PAK6 ANKRD27 DDX6 NEK1 BRAF SRGAP1 SIK2 PPIP5K2 DOCK6 DPYSL3 KIAA0930 CBL DNAH7 OTUD7A GIGYF2 TSSK1B CEP170B	7.50e-05	861	302	20	36931259
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ACACA MYCBP2 ACTB ACTG1 LANCL1 SSBP1 BIRC6 XAB2 DHX15 SLC25A3 WDR3 MLH1 TMED2 ATP11A TTC13 PCYOX1 DPYSL2 RPSA CPD CDC42BPB YARS1 SEC24C WDR6 LYN CDC27 CNOT1	7.50e-05	1297	302	26	33545068
Pubmed	Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes.	ACTB ACTG1	7.52e-05	2	302	2	21778137
GeneFamily	Glypicans	GPC3 GPC4 GPC6	2.68e-05	6	202	3	572
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SPAG1 NCF2 GTF3C3 TTC8 IFIT1B TTC13 CFAP70 CDC27	4.50e-05	115	202	8	769
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 PDGFRL FSTL5 NFASC DSCAML1 CNTN1 IL1RAPL1 MYOM2	4.62e-04	161	202	8	593
GeneFamily	6-phosphofructo-2-kinases/fructose-2,6-biphosphatases	PFKFB1 PFKFB4	7.34e-04	4	202	2	1077
GeneFamily	Dyneins, axonemal	DNAH7 DNAI2 DNAH11	8.32e-04	17	202	3	536
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DRP2 DTNA EP300	9.91e-04	18	202	3	91
GeneFamily	Actins	ACTB ACTG1	1.81e-03	6	202	2	929
GeneFamily	Phosphodiesterases	PDE1A PDE6B PDE10A	2.34e-03	24	202	3	681
GeneFamily	Non-canonical poly(A) polymerases	TENT4B TENT4A	2.51e-03	7	202	2	1318
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	2.51e-03	7	202	2	1201
GeneFamily	Ataxins\|Trinucleotide repeat containing	KMT2D PAXIP1 GIGYF2	2.64e-03	25	202	3	775
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	MEFV NLRP1 NLRP3	2.64e-03	25	202	3	994
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	NF2 RAB32 ARFGEF2	4.05e-03	29	202	3	396
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN3A SCN8A	4.25e-03	9	202	2	1203
Coexpression	GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP	LANCL1 NCF2 ACVR1B SLC25A3 ABRAXAS2 SMPDL3A ACCS DOCK10 DGKZ PAXBP1 CNOT1 HECA	3.66e-06	200	300	12	M8954
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_DN	CHL1 GAD2 ATRX ACHE LANCL1 SSBP1 PAK6 PTH2R SLC25A3 SLC25A32 AP2S1 CDC40 NF2 SCN3A GLUD1 CNOT7 ARHGEF9 PIP5K1B ALG8 TMED2 SCFD1 ADGRL2 COPS5 DOCK3 ARFGEF2 THOC5 AKTIP MOXD1 CS GUK1 PDE4DIP CDC27 ULK2	7.39e-06	1248	300	33	M17728
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	ACACB ATRX PDGFRL ACHE ETV1 ACTG1 NFASC NEK1 FAP CDC40 ATP2C2 MLH1 DTNA DDR2 RFX1 GRM8 MOXD1 CEP170B	1.30e-05	482	300	18	M12144
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	GAD2 PSEN2 LANCL1 PFKFB4 ACCS OTULINL AMPD3 FMO5 NIBAN2 SYVN1	1.41e-05	157	300	10	M9117
Coexpression	GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP	TSNAXIP1 GAD2 LUC7L3 ZNF862 PDE10A MYO5C VPS52 SCN8A RPS6KA6 CDC42BPB HECA	1.92e-05	198	300	11	M5577
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200	FAP SCN3A RAB32 PPP1R3B DDR2 DOCK10 GRIA4 RBM46 MYOM2 CACNA2D3	4.83e-06	116	293	10	gudmap_developingKidney_e15.5_Peripheral blastema_200_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500	PDE10A FAP SCN3A ADGRL2 RAB32 PPP1R3B DDR2 DOCK10 GRIA4 RBM46 MYOM2 CDC27 CACNA2D3	6.16e-06	206	293	13	gudmap_developingKidney_e15.5_Peripheral blastema_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500	CHL1 ATRX PDE10A EPB41L4A FAP SCN3A ADAMTS20 PLSCR2 ADGRL2 RAB32 PPP1R3B DDR2 DOCK10 GRIA4 GPC6 RBM46 MYOM2 CDC27 CACNA2D3	6.92e-06	421	293	19	gudmap_developingKidney_e15.5_Peripheral blastema_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	CHL1 TMEM30B MYH7 ACACA MYCBP2 MARK1 ETV1 LANCL1 BIRC6 FAP NF2 SRGAP1 SCN3A ATP2C2 ARHGEF9 ADAMTS20 DPYSL3 DRP2 PPP1R3B ARFGEF2 CPD GPC6 MOXD1 TENM4 GIGYF2 MYOM2 CACNA2D3	2.14e-05	806	293	27	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_500	ABL2 CHKA BIRC6 RBM46	3.19e-05	14	293	4	gudmap_developingGonad_e14.5_ epididymis_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200	CHL1 FAP SCN3A RAB32 PPP1R3B DDR2 DOCK10 GRIA4 RBM46 MYOM2 CACNA2D3	3.32e-05	175	293	11	gudmap_developingKidney_e15.5_Peripheral blastema_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	CHL1 TMEM30B ATRX MYCBP2 MARK1 ETV1 LANCL1 DDX6 FAP NF2 SRGAP1 SCN3A ARHGEF9 ASPM DPYSL2 DPYSL3 PPP1R3B ARFGEF2 RANBP6 CPD GPC6 MOXD1 TENM4 GIGYF2 RBM46 CDC27	5.73e-05	806	293	26	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	ATRX LUC7L3 BIRC6 NEK1 NF2 CNOT7 ASPM ADAMTS20 CNTRL RANBP6 CPD GPC6 CSTF3 GIGYF2 NEIL3	8.06e-05	339	293	15	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_1000	TMEM30B UPB1 ACADM SQOR TMEM106A SMPDL3A ATP11A SLC6A18 FMO5 APOA2 AKTIP CNDP2 HAAO CTSH	9.12e-05	304	293	14	gudmap_kidney_adult_JuxtaGlom_Ren1_k4_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000	PDE1A PDE10A CHKA BIRC6 PPIP5K2 DRP2 RNF213 TENM4 ACTR6 TPH2 GIGYF2 RBM46	1.02e-04	233	293	12	gudmap_developingGonad_e12.5_ovary_k5_1000
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000	TMEM30B MYH7 ATRX LUC7L3 ETV4 CHKA BIRC6 MYO5C NEK1 NF2 CNOT7 SCN8A ASPM ADAMTS20 PLSCR2 CNTRL RANBP6 CPD CCDC160 GPC6 TSPAN33 CNDP2 CSTF3 GIGYF2 NEIL3	1.34e-04	801	293	25	gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500	MYH7 ETV4 CHKA BIRC6 MYO5C NEK1 NF2 CNOT7 SCN8A ASPM PLSCR2 CNTRL GPC6 TSPAN33 CNDP2 NEIL3	1.79e-04	406	293	16	gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct
CoexpressionAtlas	kidney_adult_RenalCortexMixed_Std_k-means-cluster#2_top-relative-expression-ranked_500	TMEM30B UPB1 SQOR TMEM106A SMPDL3A ATP11A SLC6A18 FMO5 APOA2 CNDP2 HAAO CTSH	1.83e-04	248	293	12	gudmap_kidney_adult_RenalCortexMixed_Std_k2_500
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000	TMEM30B ATRX MYCBP2 ACTB SSBP1 CHKA BIRC6 MYO5C CNOT7 SCN8A ADAMTS20 AMPD3 ARFGEF2 CPD CCDC160 LRRK1 GPC6 TSPAN33 EFNA5 TMEM87B CSTF3 GIGYF2 CTSH HECA	2.01e-04	774	293	24	gudmap_developingKidney_e15.5_cortic collect duct_1000
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2 CACNA2D3	6.67e-10	190	302	13	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	10x3'2.3-week_17-19-Myeloid_DC-DC-DC2\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NAT2 ACTB AP2S1 PCDH15 UPK3A OTULINL DPYSL2 DTNA CNDP2 HAAO CTSH CACNA2D3	2.79e-09	174	302	12	60ee7c6f1b6972e6647a16848087cc60e0060bbe
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 PDGFRL PDE10A DOCK3 DDR2 DOCK10 CCDC80 GRID1 GPC6 EFNA5 TENM4	4.94e-09	183	302	12	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 PCDH15 ADAMTS20 USH2A CNTN1 ATP13A4 DRP2 GRID1 MUC5B TENM4 MYOM2 DNAH11	5.25e-09	184	302	12	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 PCDH15 ADAMTS20 USH2A CNTN1 ATP13A4 DRP2 GRID1 MUC5B TENM4 MYOM2 DNAH11	5.25e-09	184	302	12	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 PCDH15 ADAMTS20 USH2A CNTN1 ATP13A4 DRP2 GRID1 MUC5B TENM4 MYOM2 DNAH11	5.25e-09	184	302	12	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 DOCK3 MYH7B DTNA IL1RAPL1 EFNA5 MYOM2	6.30e-09	187	302	12	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 FSTL5 SLC10A4 CCDC85A SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	7.10e-09	189	302	12	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2	7.10e-09	189	302	12	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2	7.53e-09	190	302	12	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 GAD2 FSTL5 SLC10A4 SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	7.99e-09	191	302	12	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 FSTL5 SLC10A4 CCDC85A SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	7.99e-09	191	302	12	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2	7.99e-09	191	302	12	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 PDE1A DSCAML1 GPC4 ATP11A ATP13A4 RNF213 GRM8 DNAH7 EFNA5 NEK11 CACNA2D3	9.52e-09	194	302	12	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 GAD2 FSTL5 SLC10A4 SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	1.34e-08	200	302	12	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 GAD2 FSTL5 SLC10A4 SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	1.34e-08	200	302	12	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	PCSK5 GAD2 FSTL5 SLC10A4 SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	1.34e-08	200	302	12	a91345f268f13170c27309333603eb82400c9947
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 PDGFRL FSTL5 GPC4 DOCK3 DDR2 DOCK10 IL1RAPL1 EFNA5 TENM4	5.94e-08	185	302	11	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 FSTL5 SLC10A4 CCDC85A SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8	6.28e-08	186	302	11	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 FSTL5 SLC10A4 SCG2 PCDH15 PIP5K1B DDR2 DOCK10 GRIN2D GRM8 HAPLN1	7.00e-08	188	302	11	0501a8aa850bd2e347020abd1cac4d8075738189
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	THSD4 MYH7 ACACB NEK10 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 MYOM2	7.00e-08	188	302	11	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	THSD4 NEK10 PIP5K1B ADGRL2 DOCK3 MYH7B DTNA IL1RAPL1 EFNA5 MYOM2 CACNA2D3	7.39e-08	189	302	11	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 PDGFRL DOCK3 DTNA DDR2 CCDC80 GPC6 EFNA5 TENM4 EPDR1	7.39e-08	189	302	11	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 EFNA5 CTSH	7.79e-08	190	302	11	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 EFNA5 CTSH	8.22e-08	191	302	11	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 GPC3 PCDH15 DOCK3 DTNA DDR2 CCDC80 GRID1 EFNA5 TENM4	8.22e-08	191	302	11	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	THSD4 MYH7 ACACB PIP5K1B ADGRL2 DOCK3 MYH7B DTNA EFNA5 PDE4DIP MYOM2	8.67e-08	192	302	11	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	THSD4 ACACB TRIM55 PIP5K1B ADGRL2 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2	9.63e-08	194	302	11	c3535f7cc0076653c72db582047cff053c322397
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NCF2 UPK3A RAB32 DSE DPYSL2 KIAA0930 DTNA NIBAN2 NLRP3 CTSH CACNA2D3	1.18e-07	198	302	11	c1fe38594bd6292fcc60bdbb563376b454731d00
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NCF2 UPK3A RAB32 DSE DPYSL2 KIAA0930 DTNA NIBAN2 NLRP3 CTSH CACNA2D3	1.18e-07	198	302	11	bfc15de70a7577a2860b53e1e6826a7b5ad23040
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 EFNA5 CTSH	1.18e-07	198	302	11	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ACACA CHKA MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 CTSH	1.25e-07	199	302	11	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ACACA BTBD9 CHKA MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 CACHD1 CTSH	1.25e-07	199	302	11	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	GAD2 PDE1A BTBD6 MYCBP2 ETV1 PAK6 PTH2R SCG2 DPYSL3 HAPLN1 PDE4DIP	1.25e-07	199	302	11	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNC3 UPK3A RAB32 DSE DPYSL2 KIAA0930 DTNA LRRK1 TSPAN33 CTSH CACNA2D3	1.31e-07	200	302	11	4a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCell	10x3'2.3-week_12-13-Myeloid_DC-DC-DC3\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ACTB ACTG1 SLC25A3 UPK3A OTULINL DTNA DGKZ HAAO CTSH CACNA2D3	1.59e-07	161	302	10	39030380e04f57f8e7de231577ec3177e1b6490d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ACACA PDE6B FSTL5 GPC3 CFAP70 OTULINL DRP2 EFNA5 ZNF746 MYOM2	2.24e-07	167	302	10	e488d9c7cf4355959e3833de3bd496c13fc11b1b
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4\|TCGA-Lung / Sample_Type by Project: Shred V9	DYSF TMEM106A FAP DOCK10 RNF213 CCDC80 CPD GPC6 TMF1 XKRX	3.64e-07	176	302	10	0923b01137d6f9956ca815b41102c81e82624065
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA ETV1 ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 EFNA5 CTSH	5.20e-07	183	302	10	6847c1252d6bb105524f812658112517fd351eab
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHKA MYO5C ATP11A ATP13A4 NIBAN2 GPC6 PLEKHG4B PAXBP1 EFNA5 CACNA2D3	5.47e-07	184	302	10	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 CACHD1 EFNA5 CTSH	5.47e-07	184	302	10	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTB ETV1 ACTG1 PAK6 SCN3A GPC4 UPK3A PPP1R3B HAPLN1 DNAH11	6.04e-07	186	302	10	16092819e9148dfe64f07c737652b6e533e699f7
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 MORN4 ETV1 SLC30A2 ARHGEF9 CNTN1 DTNA IL1RAPL1 MOXD1 EPDR1	6.35e-07	187	302	10	6f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 PDE1A NEK10 GPC3 GPC4 DOCK3 CPD EFNA5 TENM4 CACNA2D3	7.70e-07	191	302	10	2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 CACHD1 EFNA5 CTSH	7.70e-07	191	302	10	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 PDGFRL DOCK3 DTNA CCDC80 GPC6 EFNA5 TENM4 EPDR1	7.70e-07	191	302	10	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ACACA ETV1 MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CACHD1 CTSH	8.07e-07	192	302	10	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 SPAG1 NEK10 SANBR CFAP70 CFAP43 DNAH7 DNAI2 NEK11 DNAH11	8.87e-07	194	302	10	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	10x5'v1-week_14-16-Myeloid_DC-DC-DC2\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ACTB ACTG1 SLC25A3 KCNC3 UPK3A OTULINL DPYSL2 CNDP2 HAAO CTSH	8.87e-07	194	302	10	a0cfc8c1cdc0722db39170e4417615b6e6b85041
ToppCell	PBMC-Control-Myeloid-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NCF2 UPK3A OTULINL RAB32 DSE DPYSL2 DTNA TSPAN33 CTSH CACNA2D3	9.74e-07	196	302	10	e1f763fa9c11bf5f4d80e79f70f9485724ac23fe
ToppCell	Control-Myeloid-cDC\|Control / Disease group, lineage and cell class	NCF2 UPK3A OTULINL RAB32 DSE DPYSL2 DTNA TSPAN33 CTSH CACNA2D3	9.74e-07	196	302	10	85d92bc226cc28384c30991cc4ebb02ec2e3ec99
ToppCell	PBMC-Control-Myeloid-cDC-cDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NCF2 UPK3A OTULINL RAB32 DSE DPYSL2 DTNA TSPAN33 CTSH CACNA2D3	9.74e-07	196	302	10	4a9095ba3f6709f88f32bf09184553f4bd211f43
ToppCell	Monocytes-cDCs\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SRGAP1 OTULINL RAB32 DSE DPYSL2 KIAA0930 NLRP3 TSPAN33 CTSH CACNA2D3	1.02e-06	197	302	10	3388c104af4c6a05988e102627e0c5e34d9dcc45
ToppCell	Severe-B_naive-5\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ACVR1B SQOR SCN3A OTULINL ATP13A4 MYH7B ABCB5 PAXBP1 NEK11	1.05e-06	153	302	9	44572f87d403e314050ab935d2cd676c33d9c287
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCF2 DYSF AP2S1 UPK3A RAB32 DSE DPYSL2 DPYSL3 NIBAN2 CTSH	1.07e-06	198	302	10	c26c909e95225440abdf558b1b858ffc06177000
ToppCell	ILEUM-non-inflamed-(3)_DC2\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RIN3 NCF2 AP2S1 UPK3A RAB32 DDR2 NLRP3 LYN CTSH CACNA2D3	1.07e-06	198	302	10	34157b3ff2c4867cacde38810999fac279051bc8
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCF2 KCNC3 UPK3A RAB32 DSE DPYSL2 DTNA TSPAN33 CTSH CACNA2D3	1.07e-06	198	302	10	d0371e2ca9e25727b35985940f6228f9d8e49727
ToppCell	10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-promonocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ACTB AP2S1 UPK3A OTULINL RAB32 DPYSL2 KIAA0930 NLRP3 CTSH CACNA2D3	1.07e-06	198	302	10	a11de3836fc1575bec5f6c701836fe2fb5a1027a
ToppCell	10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-promonocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ACTB AP2S1 UPK3A OTULINL RAB32 DPYSL2 KIAA0930 DGKZ CTSH CACNA2D3	1.07e-06	198	302	10	ff634a17195d06a8614ed1c6564937d10ca5c00d
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 ATP2C2 USH2A NWD1 CCDC160 CFAP43 DNAH7 ANKEF1 DNAH11	1.11e-06	154	302	9	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 ATP2C2 USH2A NWD1 CCDC160 CFAP43 DNAH7 ANKEF1 DNAH11	1.11e-06	154	302	9	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	control-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNC3 UPK3A RAB32 DPYSL2 KIAA0930 DTNA LRRK1 TSPAN33 CTSH CACNA2D3	1.12e-06	199	302	10	31825ba336603fe940dea6022e18ec25af110f4c
ToppCell	Influenza_Severe-Classical_Monocyte\|Influenza_Severe / Disease group and Cell class	ACTB NCF2 SQOR AP2S1 RAB32 DPYSL2 KIAA0930 NLRP3 LYN CTSH	1.12e-06	199	302	10	077ace6e0faedb8c701fcb227427204678867237
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ACACA CHKA MYO5C ATP2C2 PIP5K1B ATP11A ATP13A4 FMO5 CTSH	1.12e-06	199	302	10	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	severe_influenza-Classical_Monocyte\|severe_influenza / disease group, cell group and cell class (v2)	ACTB NCF2 DYSF AP2S1 RAB32 DPYSL2 KIAA0930 NLRP3 LYN CTSH	1.12e-06	199	302	10	899d9fa9e3d97e876da27674de89c33bff1affe9
ToppCell	Control-Control-Myeloid-cDC\|Control / Disease, condition lineage and cell class	NCF2 UPK3A RAB32 DSE DPYSL2 KIAA0930 DTNA TSPAN33 CTSH CACNA2D3	1.17e-06	200	302	10	1375d199320feb85ba06e74b10df6521e790addf
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD4 ACACA CHKA EPB41L4A MYO5C SRGAP1 ATP2C2 CPD MUC5B EFNA5	1.17e-06	200	302	10	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	severe-cDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNC3 UPK3A DSE DPYSL2 KIAA0930 DTNA CNDP2 HAAO CTSH CACNA2D3	1.17e-06	200	302	10	26e04ea276dbca5cde48335c401269c7123b54d2
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 TRPM8 HEPHL1 USH2A DTNA GRIA4 MUC5B TEAD4 CACNA2D3	1.53e-06	160	302	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAML1 TRPM8 HEPHL1 USH2A DTNA GRIA4 MUC5B TEAD4 CACNA2D3	1.53e-06	160	302	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 ACADM ACOX1 SLC30A2 ATP11A SLC6A18 FMO5 CNDP2 HAAO	1.97e-06	165	302	9	02a09d0918b103aca21c36b42c5a8a8ebad8686c
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 ACADM ACOX1 SLC30A2 ATP11A SLC6A18 FMO5 CNDP2 HAAO	1.97e-06	165	302	9	906321cb5f299d77436fb5540fd8c52d7532beca
ToppCell	severe-Myeloid-mDC\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SLC10A4 KCNC3 UPK3A DSE DPYSL2 DTNA RBM46 CTSH CACNA2D3	2.17e-06	167	302	9	50b1cea9048bd8df9aff3fb9a548443f950d1090
ToppCell	PND07-28-samps-Myeloid\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ACTB NCF2 TMEM106A PTPN6 SMPDL3A OTULINL RAB32 DOCK10 CNDP2	2.28e-06	168	302	9	87512f9e5e95333e7ffc6efa1e93bab2ba9154c6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEK10 CFAP70 NWD1 CFAP43 TDRD1 DNAH7 DNAI2 NEK11 DNAH11	2.40e-06	169	302	9	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PCSK5 MYH7 ETV1 ADCYAP1 GPC4 FUT10 CCDC160 TPH2	2.52e-06	127	302	8	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A ABL2 DYSF AREL1 FAP SMPDL3A DSE ATP13A4 AKNA	2.77e-06	172	302	9	1627fa7035b0e0bbc82a1c0f000d8231254c680a
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1A ABL2 DYSF AREL1 FAP SMPDL3A DSE ATP13A4 AKNA	2.77e-06	172	302	9	574ebdf36e45222bcd907cd2c2ee7ff50ed4573a
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD2 FSTL5 SLC10A4 SCG2 SRGAP1 DOCK10 GRIN2D GRM8 TSSK1B	2.91e-06	173	302	9	0ba64e5385fe714f876002520f8b5202809bf11e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEK10 CFAP70 PCDHB1 NWD1 MUC5B CFAP43 DNAH7 NEK11 DNAH11	3.35e-06	176	302	9	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	facs-Lung-EPCAM-3m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTB NCF2 PTPN6 OTULINL RAB32 KIAA0930 DOCK10 TSPAN33 HAAO	3.67e-06	178	302	9	01c90c3952220cc4d6a7ed9c4d575fe4f2f80fd1
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCF2 MEFV PTPN6 SMPDL3A GLUD1 OTULINL RAB32 LYN CTSH	3.84e-06	179	302	9	fa58fa0901eadb170e3d2facb2a3d8c5e624329a
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CHL1 UPB1 EPB41L4A DYSF CCDC85A ADGRL2 DOCK6 TEAD4 CDH5	4.02e-06	180	302	9	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ETV4 PFKFB1 MYO5C WDR3 ATP2C2 ASPM MUC5B TDRD1 ANO8	4.02e-06	180	302	9	271ee52ed8f21f78ddf68e52fc88fe582701675e
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UPB1 SCN3A DNTT SLC44A2 GRM8 TENM4 CTSH XKRX CDH5	4.02e-06	180	302	9	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCF2 UPK3A RAB32 DSE DPYSL2 NLRP3 TSPAN33 CTSH CACNA2D3	4.02e-06	180	302	9	2bc3fd2e4c249bf236340c5f0483747faa5c04ec
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UPK3A RAB32 DSE DPYSL2 NLRP3 TSPAN33 LYN CTSH CACNA2D3	4.21e-06	181	302	9	1b4eb044825ede6361928442524b1988c8ef58b3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UPK3A RAB32 DSE DPYSL2 NLRP3 TSPAN33 LYN CTSH CACNA2D3	4.21e-06	181	302	9	8d7ebbedc373d55e29da02ac2728b4f4118038f2
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	THSD4 MYH7 PDE10A SORT1 TRIM55 DOCK3 DTNA EFNA5 PDE4DIP	4.40e-06	182	302	9	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	10x5'v1-week_17-19-Myeloid_DC-DC-DC3\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ACTB AP2S1 MYDGF UPK3A DTNA CNDP2 HAAO CTSH CACNA2D3	4.60e-06	183	302	9	c6cac433ea7a3d60728efdc7051e09e01bb3ade5
ToppCell	3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono\|bone_marrow / Manually curated celltypes from each tissue	ACTB NCF2 SORT1 AP2S1 TRIM55 RAB32 DPYSL2 KIAA0930 CTSH	4.60e-06	183	302	9	f10e72a2e2e6cdc1984f469a60244e5fd8a10095
ToppCell	LA-11._Adipocyte\|LA / Chamber and Cluster_Paper	ACACA ACACB MYCBP2 PFKFB1 CHKA ZNF831 SIK2 PPARA TENM4	4.60e-06	183	302	9	3f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE1A CCDC85A NPFFR2 SCG2 ASPM ADGRL2 LRRK1 GPC6 GRM8	4.60e-06	183	302	9	c7e94fe3e7669db9304b249979fef7a69c30a143
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD4 MYH7 DOCK3 MYH7B DTNA IL1RAPL1 EFNA5 PDE4DIP MYOM2	5.03e-06	185	302	9	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 PCSK5 PDGFRL DOCK3 DTNA DDR2 IL1RAPL1 EFNA5 TENM4	5.03e-06	185	302	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTB ETV1 ACTG1 PAK6 SCN3A GPC4 UPK3A HAPLN1 DNAH11	5.03e-06	185	302	9	4e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PCSK5 PDGFRL MARK1 SRGAP1 GPC4 DTNA DDR2 TENM4 CACNA2D3	5.03e-06	185	302	9	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE1A ACACB NEK10 PTH2R PPARA EFNA5 TENM4 PDE4DIP CACNA2D3	5.03e-06	185	302	9	03f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TSNAXIP1 NEK10 CFAP70 NWD1 CFAP43 DNAH7 DNAI2 NEK11 DNAH11	5.03e-06	185	302	9	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TSNAXIP1 NEK10 CFAP70 NWD1 CFAP43 DNAH7 DNAI2 NEK11 DNAH11	5.25e-06	186	302	9	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
Drug	glutamic acid diethyl ester	GLUD1 GLUD2 GRIA4 GRID1 GRIN2C GRIN2D PAF1 GRM8	1.82e-08	36	300	8	CID000073960
Drug	CGP 39653	GLUD1 GLUD2 GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.84e-08	24	300	7	CID006437837
Drug	HU-211	ACTB ACTG1 DSE NLRP1 GRIA4 GRID1 GRIN2C PPARA GRIN2D GRM8 ACTR6	3.34e-07	114	300	11	CID000107778
Drug	B0683	MYH7 ACHE ACTB ACTG1 MYO5C FAP GLUD1 GLUD2 MYH7B ACTR6 TMF1	4.35e-07	117	300	11	CID006398969
Drug	gavestinel	ADCYAP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	7.14e-07	25	300	6	CID006450546
Drug	C-PP	DNTT GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.47e-06	28	300	6	CID000001228
Drug	2'(3')-O-(2,4,6-trinitrophenyl)-ADP	GLUD1 GLUD2 FEN1 ABCB5	1.98e-06	8	300	4	CID000644359
Drug	6-chloroquinoxaline-2,3-diol	GLUD1 GLUD2 GRIN2C GRIN2D	1.98e-06	8	300	4	CID000081143
Drug	GYKI 53655	GRIA4 GRID1 GRIN2C GRIN2D GRM8 CNDP2	2.26e-06	30	300	6	CID000126757
Drug	avermectin	ABCB5 GRIA4 GRID1 GRIN2C GRIN2D GRM8 MOXD1	2.98e-06	48	300	7	CID006450460
Drug	L-Glutamic Acid	GAD2 GLUD1 GLUD2 GRIA4 GRID1 GRIN2C GRIN2D GRM8	3.08e-06	68	300	8	DB00142
Drug	1tjp	PSEN2 ACTB ACTG1 MEFV NF2 DNTT DPYSL2 GRIN2C GRIN2D ACTR6	3.24e-06	116	300	10	CID005459371
Drug	T2755	ARFIP2 SCN3A GRIA4 GRID1 GRIN2C PPARA GRIN2D GRM8	4.29e-06	71	300	8	CID000005514
Drug	ibotenic acid	GAD2 ACHE NLRP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8 MOXD1 HAAO	5.10e-06	122	300	10	CID000001233
Drug	C6H12NO5P	GAD2 GRIA4 GRID1 GRIN2C GRIN2D GRM8	6.95e-06	36	300	6	CID000104962
Drug	gacyclidine	ACHE GRIA4 GRID1 GRIN2C GRIN2D GRM8	6.95e-06	36	300	6	CID000176265
Drug	lard	ACACA ACADM ACOX1 ALB RNF213 PPARA CS	7.59e-06	55	300	7	ctd:C029310
Drug	oxiracetam	ACHE SLC25A3 GRIN2C GRIN2D	9.06e-06	11	300	4	CID000004626
Drug	AC1Q68ZE	ACACA ACADM ACOX1 SCG2 GLUD1 GLUD2 AKTIP CS	9.60e-06	79	300	8	CID000000265
Drug	piracetam	ACHE GLUD1 GLUD2 ARHGEF9 NLRP1 CS	9.64e-06	38	300	6	CID000004843
Drug	YM90K	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.06e-05	23	300	5	CID005486547
Drug	Rp-cAMPS	ACTB ACTG1 PTH2R ADCYAP1 RPS6KA6 NLRP1 GRIA4 GRIN2C GRIN2D GRM8 SLC5A11 ACTR6	1.09e-05	194	300	12	CID006426631
Drug	DETC-MeSO	NLRP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.13e-05	39	300	6	CID003035711
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ATRX XAB2 SORT1 NEK1 ATP2C2 GPC4 MTMR2 ATP11A ZNF783 EFNA5 LYN NEK11	1.15e-05	195	300	12	1532_DN
Drug	Hecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	RIN3 UPB1 PSEN2 PDE6B ACVR1B GPC3 NF2 PCYOX1 AMPD3 DTNA GRM8 THOC5	1.28e-05	197	300	12	2716_DN
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; PC3; HT_HG-U133A	TSNAXIP1 GAD2 ETV1 NF2 ATP2C2 TMED2 PLSCR2 DOCK6 FMO5 DTNA PPARA PDE4DIP	1.49e-05	200	300	12	4588_UP
Drug	4-chloroaniline	MYH7 ACTB ETV1 ACTG1 PAK6 SORT1 BLMH RBM19 ATP2C2 MYH7B PAF1 ACTR6	1.64e-05	202	300	12	CID000007812
Drug	SM-2	MYH7 ACTB ACTG1 GLUD1 GLUD2 MYH7B CS ACTR6	1.96e-05	87	300	8	CID000486033
Drug	MEGX	ACHE GLUD1 GLUD2 ALB NLRP1	2.01e-05	26	300	5	CID000024415
Drug	nimodipine	ACHE ATP2C2 DPYSL3 ABCB5 GRIN2C GRIN2D PAF1 GRM8 TSPAN33 CACNA2D3	2.34e-05	145	300	10	CID000004497
Drug	L-689,560	GRIA4 GRID1 GRIN2C GRIN2D GRM8	2.44e-05	27	300	5	CID000121918
Drug	7-chlorokynurenic acid	ADCYAP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	2.63e-05	45	300	6	CID000001884
Drug	aptiganel	GRIA4 GRID1 GRIN2C GRIN2D GRM8	2.94e-05	28	300	5	CID000060839
Drug	AC1NUW3V	GRIA4 GRID1 GRIN2C GRIN2D GRM8	3.52e-05	29	300	5	CID005462126
Drug	ketobemidone	GRIA4 GRID1 GRIN2C GRIN2D GRM8	3.52e-05	29	300	5	CID000010101
Drug	thiokynurenic acid	GAD2 GRIA4 GRIN2C GRIN2D	3.60e-05	15	300	4	CID003035667
Drug	cis-2,3-piperidine dicarboxylic acid	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.18e-05	30	300	5	CID000001226
Drug	LY293558	NLRP1 GRIA4 GRIN2C GRIN2D GRM8	4.18e-05	30	300	5	CID000127894
Drug	AC1L32TU	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.18e-05	30	300	5	CID000107831
Drug	dimethylmalonate	GAD2 GLUD1 GLUD2	4.40e-05	6	300	3	CID000007943
Drug	2-methyl-1,2,3,4-tetrahydroisoquinoline	GLUD1 GLUD2 CS	4.40e-05	6	300	3	CID000015362
Drug	AC1L8SA5	GLUD1 GLUD2 CS	4.40e-05	6	300	3	CID000407285
Drug	norbiotin	GAD2 ACACA NLRP1 GRIA4 GRIN2C GRIN2D GRM8	4.55e-05	72	300	7	CID000446903
Drug	Optison	SPAG1 SLC25A32 ALB DSE	4.75e-05	16	300	4	CID000006432
Drug	L-CCG-I	ACACA GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.86e-05	50	300	6	CID000001271
Drug	NPC 12626	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.93e-05	31	300	5	CID000108099
Drug	LY235959	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.93e-05	31	300	5	CID000131938
Drug	eliprodil	GRIA4 GRID1 GRIN2C GRIN2D GRM8	4.93e-05	31	300	5	CID000060703
Drug	Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ZNF862 ACVR1B GPC3 NF2 RBM19 DTNA CPD TDRD1 EFNA5 PDE4DIP LYN	5.38e-05	193	300	11	5351_UP
Drug	LY354740	NLRP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	5.45e-05	51	300	6	CID000114827
Drug	alpha-methyl-4-carboxyphenylglycine	GRIA4 GRID1 GRIN2C GRIN2D GRM8	5.78e-05	32	300	5	CID000001222
Drug	glutarate	GAD2 ACACA ACADM ACOX1 GLUD1 GLUD2 CPD CNDP2	5.79e-05	101	300	8	CID000000743
Drug	AC1LADJ6	MYH7 ACTB ETV4 ACTG1 GLUD1 GLUD2 MYH7B CS ACTR6	5.81e-05	130	300	9	CID000486032
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	ACACB OTULINL DOCK6 USP48 ENOX2 DPYSL3 TEAD4 THOC5 RAD50 MOXD1 PDE4DIP	5.91e-05	195	300	11	5736_DN
Drug	caffeine	NAT2 PDE1A PDE6B MARK1 PDE10A ADCYAP1 CDC40 SMPDL3A ATP2C2 GLUD1 ACCS NLRP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8 CNOT1 NEK11 CACNA2D3	6.26e-05	562	300	20	CID000002519
Drug	2-amino-3-phosphonopropionic acid	GAD2 MYH7 GRIA4 GRID1 GRIN2C GRIN2D GRM8	6.46e-05	76	300	7	CID000003857
Drug	1-aminoindan-1,5-dicarboxylic acid	GRIA4 GRID1 GRIN2C GRIN2D GRM8	6.74e-05	33	300	5	CID000002071
Drug	Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A	NEK1 DOCK6 DTNA CNTRL DDR2 LRRK1 CBL IL1RAPL1 PDE4DIP HAAO CDH5	6.78e-05	198	300	11	4584_UP
Drug	Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A	RIN3 ABL2 ACACB ATRX ETV1 LANCL1 MTMR2 OTULINL GRM8 NT5DC3 CACNA2D3	7.09e-05	199	300	11	1375_UP
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; PC3; HT_HG-U133A	ETV1 ACVR1B FGD1 OTULINL DOCK6 CNTN1 DTNA PPARA CBL PDE4DIP NEK11	7.09e-05	199	300	11	4206_UP
Drug	13-methoxyibogamine	NLRP1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	7.56e-05	54	300	6	CID000065749
Drug	carbophenothion	ACHE GLUD1 GLUD2	7.62e-05	7	300	3	CID000013081
Drug	Dicamba	ACHE ACOX1 ALB	7.62e-05	7	300	3	ctd:D003996
Drug	tectoridin	ACADM ACOX1 PPARA	7.62e-05	7	300	3	ctd:C120040
Drug	D-CPPene	GRIA4 GRID1 GRIN2C GRIN2D GRM8	7.81e-05	34	300	5	CID006435801
Drug	Sulfamethoxazole	NAT2 ACHE ALB ABCB11	7.81e-05	18	300	4	ctd:D013420
Drug	3-hydroxyglutaric acid	GAD2 GRIN2C GRIN2D CDH5	7.81e-05	18	300	4	CID000181976
Drug	AC1L1JND	GAD2 ACACA SORT1 NLRP1 GRIN2C GRIN2D RFX1	8.28e-05	79	300	7	CID000005118
Drug	gabapentin	SCN3A GLUD1 GLUD2 GRIA4 GRID1 GRIN2C GRIN2D GRM8 SLC5A11 CACNA2D3	8.59e-05	169	300	10	CID000003446
Drug	kynurenine	NAT2 MYDGF GRIA4 GRID1 GRIN2C GRIN2D GRM8 HAAO	9.32e-05	108	300	8	CID000000846
Drug	R,S)-AMPA	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.04e-04	36	300	5	CID000001221
Drug	bromcresol green	GAD2 PDE6B BIRC6 SLC25A3 ALB DDR2 GRIA4 MYOM2	1.06e-04	110	300	8	CID000006451
Drug	GYKI 52466	GRIA4 GRID1 GRIN2C GRIN2D GRM8 CNDP2	1.13e-04	58	300	6	CID000003538
Drug	D-triiodothyronine	MYH7 ACACA ACHE ACOX1 ACTB ACTG1 PFKFB1 PFKFB4 ATP2C2 ALB MYH7B APOA2 PPARA AKTIP CS ACTR6	1.17e-04	409	300	16	CID000000861
Drug	unsaturated chondroitin disaccharide	GLUD1 GLUD2 ACCS ALB CCDC80 EFNA5	1.25e-04	59	300	6	CID000439481
Drug	L-BMAA	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.35e-04	38	300	5	CID000028558
Drug	CGS 19755	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.35e-04	38	300	5	CID000068736
Drug	4CPG	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.35e-04	38	300	5	CID000005115
Drug	Fluticasone propionate [80474-14-2]; Up 200; 8uM; HL60; HT_HG-U133A	ABL2 ACACB PFKFB4 ACVR1B XAB2 NF2 RPS6KA6 MOXD1 ANKEF1 CEP170B	1.38e-04	179	300	10	2928_UP
Drug	Mgamp-pnp	ACTB ACTG1 MYH7B ACTR6	1.48e-04	21	300	4	CID005311323
Drug	HA-966	GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.53e-04	39	300	5	CID000001232
Drug	phenyltriethoxysilane	GLUD1 GLUD2	1.73e-04	2	300	2	CID000013075
Drug	G-3SH	GLUD1 GLUD2	1.73e-04	2	300	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	1.73e-04	2	300	2	CID006455327
Drug	MS-30	ACHE PAF1	1.73e-04	2	300	2	CID002445109
Drug	methylmercuric bromide	GLUD1 GLUD2	1.73e-04	2	300	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	1.73e-04	2	300	2	CID000068137
Drug	Selenonium choline	ACHE CHKA	1.73e-04	2	300	2	CID000126191
Drug	quinclorac	ACHE ALB	1.73e-04	2	300	2	ctd:C489048
Drug	x 1 s	GLUD1 GLUD2	1.73e-04	2	300	2	CID000409694
Drug	CX516	GRIA4 GRIN2C GRIN2D LYN	1.79e-04	22	300	4	CID000148184
Drug	AC1N4HBY	ACACA GLUD1 GLUD2	1.79e-04	9	300	3	CID004128835
Drug	Fibric Acids	ALB APOA2 PPARA	1.79e-04	9	300	3	ctd:D058607
Drug	AP-7	ACACA GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.80e-04	63	300	6	CID000003122
Drug	AC1L1DXE	ACHE ACTB ACTG1 ADCYAP1 SORT1 SCG2 TRPM8 ALB ENOX2 GRIN2C GRIN2D ACTR6 CACNA2D3	1.83e-04	299	300	13	CID000002548
Drug	2-arachidonoylglycerol (2-AG	ACTB ACTG1 DSE CCDC80 GRIN2C PPARA GRM8 ACTR6	1.83e-04	119	300	8	CID000001541
Drug	NBQX	GAD2 SORT1 GRIA4 GRID1 GRIN2C GRIN2D GRM8	1.89e-04	90	300	7	CID003272523
Drug	adamantane	SLC25A32 GRIA4 GRIN2C GRIN2D CNDP2	1.95e-04	41	300	5	CID000009238
Disease	thyroid gland papillary carcinoma (is_implicated_in)	WDR3 BRAF SRGAP1 KMT2D	1.86e-06	10	291	4	DOID:3969 (is_implicated_in)
Disease	epilepsy (implicated_via_orthology)	CHL1 GAD2 NFASC CHKA SCN3A SCN8A KCNT1 GRIN2C GRIN2D GRM8	5.45e-06	163	291	10	DOID:1826 (implicated_via_orthology)
Disease	unipolar depression	ETV1 ACVR1B SLC30A2 ANKRD27 NPFFR2 AREL1 TRIM55 ALG8 USP48 CNTN1 TMEM161B DDR2 DOCK10 ARFGEF2 RNF213 GRID1 MUC5B CHD7 GRM8 CDC42BPB DNAH7 ANO8 TSPAN33 HAPLN1 NBAS SPATA16 GIGYF2 CACNA2D3	2.71e-05	1206	291	28	EFO_0003761
Disease	Moyamoya disease (implicated_via_orthology)	ACTB ACTG1 POTEKP	5.13e-05	8	291	3	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTB ACTG1 POTEKP	5.13e-05	8	291	3	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTB ACTG1 POTEKP	5.13e-05	8	291	3	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTB ACTG1 POTEKP	5.13e-05	8	291	3	DOID:14004 (implicated_via_orthology)
Disease	Colorectal Carcinoma	CHL1 ACACA PDGFRL FSTL5 ETV1 PAK6 DSCAML1 BRAF FEN1 MLH1 CNTN1 DPYSL2 ABCB5 GRID1 HAPLN1 ABCB11 CTSH CDH5 EP300	7.96e-05	702	291	19	C0009402
Disease	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3 GPC4	9.69e-05	2	291	2	312870
Disease	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	ACTB ACTG1	9.69e-05	2	291	2	C1855722
Disease	Baraitser-Winter syndrome	ACTB ACTG1	9.69e-05	2	291	2	cv:C1853623
Disease	Simpson-Golabi-Behmel syndrome type 1	GPC3 GPC4	9.69e-05	2	291	2	cv:C0796154
Disease	Fryns-Aftimos Syndrome	ACTB ACTG1	9.69e-05	2	291	2	C1853623
Disease	Congenital neurologic anomalies	ACTB ACTG1 FGD1	1.08e-04	10	291	3	C0497552
Disease	Cranioschisis	ACTB ACTG1 FGD1	1.08e-04	10	291	3	C0265541
Disease	intestinal atresia (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.08e-04	10	291	3	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.08e-04	10	291	3	DOID:13832 (implicated_via_orthology)
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPG RNF213 CDC42BPB	1.48e-04	11	291	3	DOID:0060669 (implicated_via_orthology)
Disease	Craniofacial Abnormalities	ATRX ACTB ACTG1 GPC4 FGD1 GPC6 HAPLN1 EP300	1.67e-04	156	291	8	C0376634
Disease	Mental Retardation, X-Linked	ATRX ARHGEF9 FGD1 IL1RAPL1	1.81e-04	29	291	4	C1136249
Disease	distal myopathy (implicated_via_orthology)	MYH7 DYSF MYH7B	1.96e-04	12	291	3	DOID:11720 (implicated_via_orthology)
Disease	Adenocarcinoma of lung (disorder)	TTF1 NEK1 BRAF RPS6KA6 MLH1 ALB DDR2 RPSA EP300	2.22e-04	206	291	9	C0152013
Disease	Large cell carcinoma of lung	NEK1 RPS6KA6 DDR2 CDC42BPB	2.68e-04	32	291	4	C0345958
Disease	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	GPC3 GPC4	2.89e-04	3	291	2	C0796154
Disease	Simpson-Golabi-Behmel syndrome	GPC3 GPC4	2.89e-04	3	291	2	cv:C4317043
Disease	Epilepsies, Partial	SCN3A KCNT1	2.89e-04	3	291	2	C0014547
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	2.89e-04	3	291	2	DOID:885 (biomarker_via_orthology)
Disease	Left ventricular noncompaction	MYH7 MYH7B DTNA	3.19e-04	14	291	3	C1960469
Disease	Adenocarcinoma of large intestine	PDGFRL BRAF MLH1 CDC42BPB EP300 NEK11	3.85e-04	96	291	6	C1319315
Disease	Growth Disorders	ATRX ACHE FGD1 CBL	4.26e-04	36	291	4	C0018273
Disease	glycine measurement	ACADM PDGFRL PTH2R KLKB1 RANBP6 GRM8 TENM4	4.36e-04	137	291	7	EFO_0009767
Disease	Colorectal Neoplasms	ETV1 BRAF FEN1 MLH1 ABCB5 GRID1 HAPLN1 ABCB11 CDH5 EP300	4.62e-04	277	291	10	C0009404
Disease	sporadic amyotrophic lateral sclerosis	PDGFRL NFASC PTH2R RBM19 TRPM8 GRID1 MYOM2	4.96e-04	140	291	7	EFO_0001357
Disease	Schizophrenia	CHL1 GAD2 PSEN2 ACHE ACTB NFASC BTBD9 ERVW-1 ADCYAP1 PTPN6 DIO3 GNPAT GRIA4 GRID1 GRIN2C PPARA GRIN2D GRM8 TENM4 TPH2	5.34e-04	883	291	20	C0036341
Disease	Acne	MEFV NLRP3	5.74e-04	4	291	2	C0702166
Disease	signal-transducing adaptor protein 1 measurement	ALB RPSA	5.74e-04	4	291	2	EFO_0803075
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	5.74e-04	4	291	2	EFO_0020830
Disease	Pyoderma Gangrenosum	MEFV NLRP3	5.74e-04	4	291	2	C0085652
Disease	Acne Vulgaris	MEFV NLRP3	5.74e-04	4	291	2	C0001144
Disease	chemokine (C-C motif) ligand 27 measurement	NEK10 USP48 PPARA SLCO1B7 EFNA5	6.46e-04	70	291	5	EFO_0008082
Disease	Bone marrow hypocellularity	DNAJC21 FANCM FANCI	6.94e-04	18	291	3	C1855710
Disease	alcoholic hepatitis (biomarker_via_orthology)	PPARA NLRP3 ABCB11	6.94e-04	18	291	3	DOID:12351 (biomarker_via_orthology)
Disease	peptide measurement	ABL2 KLKB1 FMO5 NLRP1 CNDP2 CACNA2D3	7.57e-04	109	291	6	EFO_0010520
Disease	reaction time measurement	SLC28A3 NCF2 EPB41L4A DYSF CCDC85A MAIP1 ADGRL2 CNTN1 DPYSL2 DGKZ NLRP1 KMT2D EFNA5 TMEM87B GIGYF2 CDC27	9.16e-04	658	291	16	EFO_0008393
Disease	Insulinogenic index measurement	MYCBP2 PPIP5K2	9.50e-04	5	291	2	EFO_0009961
Disease	Usher Syndrome, Type II	PCDH15 USH2A	9.50e-04	5	291	2	C1568249
Disease	muscular disease (implicated_via_orthology)	ACACA ACACB	9.50e-04	5	291	2	DOID:0080000 (implicated_via_orthology)
Disease	Bipolar Disorder	GAD2 PSEN2 FSTL5 ACTB PDE10A ERVW-1 ADCYAP1 SCN8A DPYSL2 GRID1 TENM4 SEC24C TPH2	9.94e-04	477	291	13	C0005586
Disease	Attention Deficit Disorder	FGD1 GRM8 TPH2	1.27e-03	22	291	3	C0041671
Disease	Minimal Brain Dysfunction	FGD1 GRM8 TPH2	1.27e-03	22	291	3	C1321905
Disease	hip bone mineral density, fat body mass	PTH2R GRID1 NEK11	1.27e-03	22	291	3	EFO_0005409, EFO_0007702
Disease	hypertrophic cardiomyopathy (is_implicated_in)	MYH7 MYH7B CS	1.27e-03	22	291	3	DOID:11984 (is_implicated_in)
Disease	cholangiocarcinoma (is_implicated_in)	NAT2 BRAF ALB	1.27e-03	22	291	3	DOID:4947 (is_implicated_in)
Disease	myopathy (implicated_via_orthology)	MYH7 ACTB MTMR2 MYH7B	1.28e-03	48	291	4	DOID:423 (implicated_via_orthology)
Disease	colorectal cancer (is_implicated_in)	PDGFRL BRAF NF2 MLH1 DDR2 EP300	1.30e-03	121	291	6	DOID:9256 (is_implicated_in)
Disease	chronotype measurement	MYCBP2 PFKFB4 BTBD9 PDE10A BIRC6 TTC8 RBM19 SCN8A PCDH15 RPS6KA6 USP48 PCYOX1 DOCK3 DTNA SLC44A2 GPC6 IL1RAPL1 KMT2D EFNA5	1.31e-03	882	291	19	EFO_0008328
Disease	3-hydroxyisobutyrate measurement	PARP11 GIGYF2	1.42e-03	6	291	2	EFO_0010983
Disease	WILMS TUMOR 1	GPC3 GPC4	1.42e-03	6	291	2	194070
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	1.42e-03	6	291	2	DOID:1825 (biomarker_via_orthology)
Disease	Fever, response to sulfasalazine	PDE10A OTUD7A	1.42e-03	6	291	2	EFO_0008324, HP_0001945
Disease	vasoactive peptide measurement	KLKB1 AMPD3	1.42e-03	6	291	2	EFO_0005196
Disease	Wilms tumor 1	GPC3 GPC4	1.42e-03	6	291	2	cv:CN033288
Disease	bilirubin measurement	BIRC6 SIK2 MYDGF TRPM8 ALB ADGRL2 CACHD1 NLRP3 SLCO1B7 SPATA16 GIGYF2 DNAH11	1.59e-03	442	291	12	EFO_0004570
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTMR2 FGD1 YARS1	1.65e-03	24	291	3	DOID:10595 (implicated_via_orthology)
Disease	Attention deficit hyperactivity disorder	FGD1 GRM8 TPH2	1.65e-03	24	291	3	C1263846
Disease	carotid artery intima media thickness	THSD4 PTH2R PCDH15 FUT10 CHD7 GPC6 HAPLN1 SPATA16 RBM46 NEIL3 NEK11 DNAH11	1.85e-03	450	291	12	EFO_0007117
Disease	malignant mesothelioma (is_implicated_in)	NAT2 ACVR1B	1.97e-03	7	291	2	DOID:1790 (is_implicated_in)
Disease	Urogenital Abnormalities	DDX6 FGD1	1.97e-03	7	291	2	C0042063
Disease	bipolar disorder (implicated_via_orthology)	ETV1 ETV4	1.97e-03	7	291	2	DOID:3312 (implicated_via_orthology)
Disease	Uveoretinal Coloboma	ACTB ACTG1	1.97e-03	7	291	2	C4554007
Disease	Hereditary Autoinflammatory Diseases	MEFV NLRP3	1.97e-03	7	291	2	C0751422
Disease	Hidradenitis Suppurativa	MEFV NLRP3	1.97e-03	7	291	2	C0162836
Disease	MASA syndrome (implicated_via_orthology)	CHL1 NFASC	1.97e-03	7	291	2	DOID:0060246 (implicated_via_orthology)
Disease	attempted suicide	PCSK5 CNST FSTL5 PCDH15 OTUD7A GIGYF2 CACNA2D3	2.01e-03	178	291	7	EFO_0004321
Disease	Pancytopenia	DNAJC21 FANCM FANCI	2.09e-03	26	291	3	C0030312
Disease	cytokine measurement	PCSK5 CATSPERE ACACA MYCBP2 PAK6 PDE10A PPIP5K2 ADGRL2 ATP13A4 ARFGEF2 GPC6 ABCB11	2.25e-03	461	291	12	EFO_0004873
Disease	Neurodevelopmental Disorders	POGZ SCN8A CDC42BPB GIGYF2 CACNA2D3	2.31e-03	93	291	5	C1535926
Disease	Colorectal cancer	PDGFRL BRAF EP300	2.33e-03	27	291	3	cv:C0346629
Disease	Neoplasm of the large intestine	PDGFRL BRAF EP300	2.33e-03	27	291	3	cv:C0009404
Disease	COLORECTAL CANCER	PDGFRL BRAF EP300	2.33e-03	27	291	3	114500
Disease	essential tremor	NAT2 NFASC DSCAML1 DHX15 TMEM161B NLRP1	2.36e-03	136	291	6	EFO_0003108
Disease	lung small cell carcinoma (is_implicated_in)	ATRX ACVR1B KMT2D	2.59e-03	28	291	3	DOID:5409 (is_implicated_in)
Disease	coiled-coil domain-containing protein 80 measurement	KLKB1 CCDC80	2.61e-03	8	291	2	EFO_0020268
Disease	Bilateral Cryptorchidism	ATRX CBL	2.61e-03	8	291	2	C0431663
Disease	Unilateral Cryptorchidism	ATRX CBL	2.61e-03	8	291	2	C0431664
Disease	Ewings sarcoma	ETV1 ETV4	2.61e-03	8	291	2	C0553580
Disease	Nephroblastoma	GPC3 GPC4	2.61e-03	8	291	2	cv:C0027708
Disease	Abdominal Cryptorchidism	ATRX CBL	2.61e-03	8	291	2	C1563730
Disease	Inguinal Cryptorchidism	ATRX CBL	2.61e-03	8	291	2	C1563731
Disease	Hereditary Wilms tumor	GPC3 GPC4	2.61e-03	8	291	2	cv:C0677779
Disease	Kidney Wilms tumor	GPC3 GPC4	2.61e-03	8	291	2	cv:CN305775
Disease	serum metabolite measurement	NAT2 UPB1 PSEN2 ACADM ZNF862 PKD1L1 SLC28A3 PDE10A GFUS NPFFR2 PCDH15 TRPM8 DOCK6 KLKB1 CDC42BPG DPYSL2 DDR2 CNDP2 MYOM2	2.84e-03	945	291	19	EFO_0005653
Disease	Drug-Induced Stevens Johnson Syndrome	ALB COPS5 EP300	2.87e-03	29	291	3	C1274933
Disease	hippocampus volume change measurement, age at assessment	PCDH15 LRRK1 TSPAN33	2.87e-03	29	291	3	EFO_0008007, EFO_0021492
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	ALB COPS5 EP300	2.87e-03	29	291	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	ALB COPS5 EP300	2.87e-03	29	291	3	C3658302
Disease	Toxic Epidermal Necrolysis	ALB COPS5 EP300	2.87e-03	29	291	3	C0014518
Disease	colorectal cancer	THSD4 CABLES2 RIN3 BTBD9 SRGAP1 FEN1 MLH1 KCNT1 SLC6A18 DOCK3 AMPD3 RANBP6 HAPLN1 TPH2	2.91e-03	604	291	14	MONDO_0005575
Disease	Stuttering	SCG2 PCDH15 CFAP70 SEC24C TMEM87B SPATA16	3.02e-03	143	291	6	HP_0025268
Disease	Stevens-Johnson Syndrome	ALB COPS5 EP300	3.16e-03	30	291	3	C0038325

Protein segments in the cluster

Peptide	Gene	Start	Entry
YVDYGNFEILSLMRL	TDRD1	576	Q9BXT4
YYGMNALRAKVSLIE	TTF1	756	Q15361
YTAEEKIFAQRLMRY	ACHE	496	P22303
YVSQDFYRDMDIAKL	ACTR6	211	Q9GZN1
NVMKAYSLVDREVGY	EVI5L	181	Q96CN4
YMAAYIENAKQVGRL	COPS5	116	Q92905
SYIKIFDVGTRYMVN	PFKFB1	216	P16118
ENLVAYARKVEGDMY	EP300	606	Q09472
LFEYILLYKDGVMFQ	EPDR1	91	Q9UM22
MEELTLKGVTQYYAY	DDX6	301	P26196
QSDVYAFGIVLYELM	BRAF	636	P15056
YSFIIKDRSYMIEDF	CFAP43	326	Q8NDM7
SRYKRNMFATESYII	CNTRL	391	Q7Z7A1
GVMKDIRAIYQVYNA	ABRAXAS2	201	Q15018
AKDVFLGMFLYEYAR	ALB	346	P02768
QYFQTVTDYGKDLME	APOA2	36	P02652
EQRNVSGGYLVLYKM	BIRC6	816	Q9NR09
FIDYYGDILVKMENN	CATSPERE	501	Q5SY80
LSQVYDLLEKGYRME	ABL2	491	P42684
LRYYVGDTMDVLFEK	HAAO	116	P46952
DEVYMLSVFEKSVGY	ACCS	286	Q96QU6
DYKEYAFAIIIMSII	ATP13A4	221	Q4VNC1
AKRGLYYSLVMSQDI	ABCB5	611	Q2M3G0
YAMFYGDLAEVKSEI	BTBD6	166	Q96KE9
FDYLNRYTVTIEGMI	ACVR1B	291	P36896
TDYLMKILTERGYRF	POTEKP	186	Q9BYX7
TDYLMKILTERGYSF	ACTB	186	P60709
TDYLMKILTERGYSF	ACTG1	186	P63261
FYADIYMEDGLIKQI	DPYSL3	31	Q14195
ARFNKEVMYAYVDQL	ARFGEF2	701	Q9Y6D5
QVLMYARRVFYKIDT	AKTIP	176	Q9H8T0
AVMGIDFTLRYFYKV	CACHD1	806	Q5VU97
IDIYEALYVQMSKFE	DNAH11	1086	Q96DT5
RRMLETAYKYFEGID	DNAH11	2761	Q96DT5
LLNIESEMIKFASYY	ABCB11	131	O95342
MYDQVLKFGAYIVDG	ACACA	2056	Q13085
YLMLVEVFESEYSRK	ADGRL2	936	O95490
SAMDVAKAYADYRII	ANKEF1	626	Q9NU02
TLMTVKQYEAARLEY	ARFIP2	221	P53365
LMVFKLAQAYYESTR	FLG	76	P20930
MRDAKIYQIYEGTSQ	ACADM	391	P11310
VIRFGYDSNMYVLER	CEP170B	86	Q9Y4F5
YINIRKALVTGYFMQ	DHX15	686	O43143
MEIVYVYVKKRSEFG	DNAI2	1	Q9GZS0
RMTKYSILRGDYQDA	CDH5	291	P33151
ASRRTIQLYEMYFKD	CHD7	1051	Q9P2D1
FEELVEMKSNYYSFI	ASPM	451	Q8IZT6
IYFMKGALEEVIRYC	ATP2C2	506	O75185
AGTNYFYLLKDMVED	ADAMTS20	661	P59510
RLISELRKEYGMTYN	CCDC80	696	Q76M96
YRFQMGFVRDLEKQY	ARHGEF9	156	O43307
YLGGEYFARMVKEVA	AMPD3	411	Q01432
NFYKVYTVVDEMFLA	AP2S1	106	P53680
LSLFYIGFYLKDMER	ANO8	451	Q9HCE9
GIMQKVAGERYVYKF	ETV4	406	P43268
RVVYSMTNGDLFLYE	NWD1	1361	Q149M9
QEGVFKMCYNYRIRV	MUC5B	1581	Q9HC84
EAMSRIYYRGAKAAI	RAB24	71	Q969Q5
KCNREYMGGRYIEVF	RBM19	351	Q9Y4C8
YMGGRYIEVFREKNV	RBM19	356	Q9Y4C8
RGYAFVMYTTKEEAQ	RBM46	101	Q8TBY0
EMRKIYTTVLFANIY	NPFFR2	316	Q9Y5X5
ERFGNMTRVYYKEAV	RAB32	86	Q13637
NYNYRVVMLKGDTAL	RAD50	1181	Q92878
MAAGFKTVEPLEYYR	EXOSC8	1	Q96B26
FYAESLVETYGKIMN	CDC42BPG	276	Q6DT37
IYATGALAKAVYERM	MYH7	421	P12883
DAIRMYRQSKELYGT	NIBAN2	211	Q96TA1
NGKLYALRTMDYEAI	PCDHB1	511	Q9Y5F3
MFDTLVKIYKYEGVR	SLC25A32	166	Q9H2D1
QSAEAGIFVLIYKMY	SLC10A4	371	Q96EP9
DMYDQVLKFGAYIVD	ACACB	2166	O00763
YNLIFKYVGTMEASE	ANKRD27	221	Q96NW4
EMFREVKYYAVGDID	PAXIP1	11	Q6ZW49
GAMQVKQAFDYAYVV	TENT4B	376	Q8NDF8
SQQADVRLMLYEGFY	FANCI	596	Q9NVI1
LYNIIKNREGYEMVF	GAD2	481	Q05329
DNFLLTVMAYDRYVA	OR1F12P	111	Q8NHA8
HFNVVEMYKSYLVGE	PAK6	461	Q9NQU5
YEVFKVLYSNMLGEE	SLC25A3	141	Q00325
AEMLGSVIKNYEDYF	MAGEA11	246	P43364
IYYDEKGRKFVNILM	MAIP1	211	Q8WWC4
GVIYMLIQAYKVFRE	LANCL1	281	O43813
YVYSGVETLGKELFM	NEIL3	71	Q8TAT5
YRESFEENGSLYIVM	NEK1	66	Q96PY6
QRGMLYYQTEKYDLA	NCF2	76	P19878
QDERVYMSQKGDLYF	CHL1	176	O00533
VIDVRIGMQYFSEYS	HECA	501	Q9UBI9
AYGDLEMVRYLLSKR	LRRK1	96	Q38SD2
GIEFAPMYKINYSRD	DDR2	111	Q16832
FYADIYMEDGLIKQI	DPYSL2	31	Q16555
YRIYDMENVLLGLFS	GPC3	311	P51654
LKRYYVVGNVNLEEM	GPC4	146	O75487
AYFERLYVIQSGTIM	DIO3	256	P55073
VSEFIKYEISFNVYM	GLB1L3	326	Q8NCI6
RYFSVEEYVSRMKEI	HSP90AB2P	241	Q58FF8
AMREYYNEKLIDIFQ	SMPDL3A	266	Q92484
EEYMVDKALYLSGYR	ENOX2	171	Q16206
GKTFIAAVVMYNFYR	FANCM	116	Q8IYD8
LDTLLYQSFVKDYMI	KCNT1	956	Q5JUK3
MLFYVRRKLAYSGSE	KIAA0930	51	Q6ICG6
YGRRVNYTMDVFELK	GRIA4	366	P48058
ESARYLRQGYQEMTK	MYH7B	51	A7E2Y1
DDIVYMGQDGTVYRK	PCSK5	1821	Q92824
VEDVLDKFMRIYRYQ	PCYOX1	156	Q9UHG3
MYEIKNSFGQRIYFA	PLSCR2	116	Q9NRY7
YKTFLENDRLYIVME	NEK10	591	Q6ZWH5
YKIEIMLFYRNHFGA	IL1RAPL1	381	Q9NZN1
ALYFGNRKQLEEMYQ	PDE10A	626	Q9Y233
QAGIFVERMYRKTYH	PDE1A	126	P54750
IQMYYELGVVRKFQI	PDE6B	521	P35913
MEVASYLVAQYGEQR	NLRP1	51	Q9C000
EGLYFDTETYNALMK	PIP5K1B	236	O14986
LVYIQYMKFARRAEG	CSTF3	376	Q12996
IMQKVAGERYVYKFV	ETV1	401	P50549
RDLSYIKIMDVGQSY	PFKFB4	211	Q16877
NLIYSHRMLEYGEYK	MPP4	486	Q96JB8
MQKLGTEVFEEVYNY	NEK11	576	Q8NG66
TVTNYRLYFKSMERD	MTMR2	106	Q13614
KFLEVIANASGYMYE	DSE	176	Q9UL01
FMKVGYERDFLRYLQ	LUC7L3	76	O95232
EVMDYTFIGVFKLIY	LRRC52	91	Q8N7C0
FGYSYAKRMIDVQNR	GFUS	141	Q13630
VFDDGRYVYLVTDLM	RPS6KA6	486	Q9UK32
VKMATLLVTYYGEEY	MEFV	51	O15553
EEMIGYYLTSAQERF	OTUD7A	651	Q8TE49
FYAESLVETYGKIMN	CDC42BPB	281	Q9Y5S2
YKFLQEMRGYVQDLL	PAXBP1	441	Q9Y5B6
EGFLLSVMAYDRYVA	OR5J2	111	Q8NH18
YFVEQEKVVSMFYTL	OR5J2	266	Q8NH18
GFYTVYRNVFEMIAK	DNAJC21	106	Q5F1R6
KVQFVIDAVYSMAYA	GRM8	401	O00222
FGYIKQGLYLVTEME	NBAS	486	A2RRP1
GAMQVKQVFDYAYIV	TENT4A	476	Q5XG87
EALKFIMLYQVTEVY	OTULINL	241	Q9NUU6
GNMFYVFYEDGIKVI	FSTL5	451	Q8N475
AQDLEMYGVNYFAIR	NF2	211	P35240
MAGLRYSVKVYVLNE	PPP4R3C	1	Q6ZMV5
IFTDSYSRYRKQMAV	ADCYAP1	136	P18509
RVLIGDYINGDSKYM	PARP11	281	Q9NR21
YSNYKLEMVVVNGRG	NFASC	901	O94856
KDTGNYSVMAYRLII	PCDH15	1171	Q96QU1
MRKTEYISTEFNRYG	PAF1	131	Q8N7H5
FQFVGAYMKETYHRI	ACOX1	341	Q15067
IRKYNYVAMDTEFPG	CNOT7	31	Q9UIV1
YVYRFLAQGTMEDKI	ATRX	2161	P46100
YFGRKVAIDASMSIY	FEN1	26	P39748
LKRYYTGGNVNLEEM	GPC6	146	Q9Y625
KDYYFVTREVMQRDI	GUK1	51	Q16774
YAFELKMNDLTYFVL	DOCK10	256	Q96BY6
QKNIEVTMYVLYADG	DOCK3	441	Q8IZD9
VTMYVLYADGEILKD	DOCK3	446	Q8IZD9
MGGLYEAVNEVYKNL	DOCK6	1696	Q96HP0
YRYGREEMLALFLKD	GIGYF2	41	Q6Y7W6
AVFSEYVKTMLRNGY	GNPAT	221	O15228
YVKTMLRNGYAPVEF	GNPAT	226	O15228
VDKGKRVLVMTNDYY	CACNA2D3	591	Q8IZS8
RVLVMTNDYYYTDIK	CACNA2D3	596	Q8IZS8
SVYSIRMYSFNKIGR	DSCAML1	956	Q8TD84
RYEMYARELAEAVKS	UPB1	361	Q9UBR1
VQAKISSIEFGYMDY	CHKA	426	P35790
MKYNLGLDLRTAAYV	GLUD1	526	P00367
ISRAILDEYYRMFGK	CFAP70	521	Q5T0N1
FEMAAAYYKERLVRE	CFAP70	651	Q5T0N1
SMDADGFYRIIAQYK	FUT10	261	Q6P4F1
AQVLEYFRMYAKEFD	FMO5	86	P49326
EMNYYTVLFGVSRAL	CS	416	O75390
LRLYDVTFENAGMYQ	CNTN1	376	Q12860
DYIDIFLNVYDVMIK	DNAH7	421	Q8WXX0
KRTFEMAYVDLAETY	IFIT1B	336	Q5T764
TGFVMLVVYIRYQDQ	TMEM30B	331	Q3MIR4
YKDLSEFLRGLVMNY	CPD	936	O75976
YYELEMAKIRGELSV	CCDC160	266	A6NGH7
QVYHGLMERYLSVKS	AKNA	756	Q7Z591
AQIIGLRMHYKYFET	AREL1	586	O15033
VEYLSNMVGGRKTLY	BLMH	286	Q13867
RYTAGVMHKEVALYL	CCDC85A	131	Q96PX6
EYILYNKGIMGEDTY	CTSH	191	P09668
EQRYGMIRTFYIAAE	HEPHL1	726	Q6MZM0
QKYDEVMATYILLGR	MARK1	356	Q9P0L2
YIITEYMAKGSLLDF	LYN	316	P07948
IAEGMAYIERKNYIH	LYN	351	P07948
MDIEAYFERIGYKNS	NAT2	1	P11245
VMVYGRYDQFLREVL	DTNA	161	Q9Y4J8
EDKTERYVLYMVNFD	EFNA5	71	P52803
DFSKRYMDYSVGILI	GRID1	531	Q9ULK0
RYQDYKITQRMVCAG	KLKB1	551	P03952
KFLNRNAYIMIAIYG	SLC44A2	556	Q8IWA5
RYEGKMETLGENEYF	CBL	101	P22681
YVGEQYCVARMLKSV	DGKZ	111	Q13574
MDTVQLGYLFRKYIA	FAM186A	2146	A6NE01
EAFTMLLKYIYTGRA	BTBD9	86	Q96Q07
YLRTAKSLEMYGVDL	EPB41L4A	196	Q9HCS5
TLINYMAKFAYRGVL	SEC24C	846	P53992
GRAYFELSEYMQAER	CDC27	506	P30260
YRTDRVMFQDKEYSI	DYSF	1716	O75923
YELISAFVTKGVYML	PKD1L1	401	Q8TDX9
VTVAMAYVYFEKLVL	CABLES2	381	Q9BTV7
MKYNLGLDLRTAAYV	GLUD2	526	P49448
ADNMDFYYTKLLQGV	CNST	701	Q6PJW8
AAFMEEVKSRGPYIY	DRP2	146	Q13474
KIQSYERMEFAVYYE	PPP1R3B	201	Q86XI6
SAKFLGELYNYRMVE	UPF2	871	Q9HAU5
GELYNYRMVESAVIF	UPF2	876	Q9HAU5
FGSLVQDYKVYSLEM	RIN3	616	Q8TB24
SDYLKEVDVFVSMGY	HAPLN1	86	P10915
VTLLKYGVYEAIFAM	PPARA	306	Q07869
ENFILAVMAYDRYIA	OR1Q1	111	Q15612
AMYYLLEEEKEGRTN	NLRP3	531	Q96P20
DFQMEQYIYKRKSDG	RPSA	31	P08865
YQEFLIRKFSGNMTY	TAS2R41	156	P59536
DNKAVYMLYTELFTG	SYVN1	206	Q86TM6
MFYAVATKIRDENTY	TMEM106A	191	Q96A25
EKETMFYYRTVNGLQ	USH2A	181	O75445
IMTFGQSKLYRSEDY	SORT1	136	Q99523
QKIMYLSEAYFRKTG	SQOR	206	Q9Y6N5
MFNIYIKRAAEIYGV	XAB2	631	Q9HCS7
FYYKLSQELNGDMER	ERVW-1	346	Q9UQF0
YYENVIKAMLESIGV	YARS1	96	P54577
EQFYFMKLREYLEGS	SRGAP1	436	Q7Z6B7
STVELQKMVARVFYY	TMEM161B	356	Q8NDZ6
TRMQKAGFLYYEDLV	DNTT	286	P04053
EGRMPFEKYTNYEVV	TEC	561	P42680
MYYLIEHRVAQAKGE	RFX1	886	P22670
GIMYRAIEADIEKYI	NT5DC3	261	Q86UY8
VQTKLIMLVDDFYYG	POGZ	461	Q7Z3K3
LHVKEMYDYQGRSYL	CDC40	241	O60508
MYGEYVKNFDRAVEL	FGD1	466	P98174
DQELGEYLARMLVKY	SCG2	501	P13521
MLYLVTEYAKNGEIF	SIK2	91	Q9H0K1
FIYIFTKISVDMYAG	SLC5A11	151	Q8WWX8
KLVYIDEMGVRYEFV	SPATA16	126	Q9BXB7
MKVYENYSFEELRFA	MYCBP2	2376	O75592
TDYLMKILTERGYRF	POTEI	886	P0CG38
DGKYEAKQLRTFYQM	IARS2	216	Q9NSE4
EYADKVFTYIFILEM	SCN3A	1241	Q9NY46
MVARLIGYKTFFNEF	SLC28A3	506	Q9HAS3
SLFAKMYVDIGYVDL	SLCO1B7	181	G3V0H7
AMFYSIRKQYISEES	MLH1	681	P40692
TDIVYDMKRGFVYLQ	PDGFRL	221	Q15198
RDLLISEMKYFAEYL	SANBR	166	Q6NSI8
QMLVYYAKELREGFV	RANBP6	691	O60518
VVYVYGMKRFCDDIA	SLC6A18	491	Q96N87
FIDLVYIKRYEGNMN	STARD6	111	P59095
YMERAAESYGKVVDL	GTF3C3	471	Q9Y5Q9
YILSHVAKYFDQEML	ALG8	76	Q9BVK2
ILENFYDKTSYIIMF	CLGN	166	O14967
YIEGTKMLAAYLYEV	CNDP2	456	Q96KP4
YMRGEQYDQAKLSRI	CNOT1	546	A5YKK6
LGFTYLRLKDNYMEI	ATP11A	521	P98196
TVMARAEYFRNVDYL	FAP	681	Q12884
FDDLAMFVYTKQYGL	PEX11G	66	Q96HA9
MFVYTKQYGLGAQEE	PEX11G	71	Q96HA9
FGLRDYYSLIKMVFA	RNF213	2951	Q63HN8
RSYLGRLMKVQYEEV	VPS52	301	Q8N1B4
GMQAFDYLEASKVIY	TSPAN33	206	Q86UF1
RYNTILQMYGEKAEE	TMF1	1051	P82094
GQVINMRYLEYFEKI	TTC13	606	Q8NBP0
DYLYGILEERKNEMT	TRIM55	216	Q9BYV6
QEMVDTFLYLAKVYV	TTC8	281	Q8TAM2
YRDVMLENYGNVFSL	ZNF3	76	P17036
QGNTMTFIYREKDIY	TRDV2	61	A0JD36
SGLRLFYTMDIRKYD	MOXD1	321	Q6UVY6
FYTMDIRKYDAGVIE	MOXD1	326	Q6UVY6
RHEEQFGMYVIYSKN	PLEKHG4B	886	Q96PX9
LALSTQIYYMGRFKI	SIDT1	641	Q9NXL6
SRIYLEGKIDYGEYM	SSBP1	106	Q04837
RRAMAYETLEQYGKA	SPAG1	526	Q07617
EYRFKYVLVNMSTGL	UPK3A	161	O75631
IYLGEVLKTYNVAMD	PSEN2	186	P49810
DAYGRMKEVQYEIFR	TENM4	2146	Q6N022
EDKMRLFLIYYISTQ	SCFD1	451	Q8WVM8
YQLTLRAAGKTYMIF	SCN8A	376	Q9UQD0
DQFEYVMYGKVYRIE	POLR2H	86	P52434
FAYLKDGDVMLYRAL	WDR6	671	Q9NNW5
EGKMYGRNELIARYI	TEAD4	71	Q15561
GKQEFFERLYVMYTV	PTH2R	136	P49190
VYRQRRKYFVDVAMG	TPH2	186	Q8IWU9
SGMVQTEAQYKFIYV	PTPN6	496	P29350
EQACVGIYIRYFKQM	ZNF862	636	O60290
GIYIRYFKQMEVKES	ZNF862	641	O60290
VAMTLGQIYYLKRFF	TMED2	181	Q15363
IFLGMLEKAVFYSEY	TMEM87B	256	Q96K49
MFQQTEDIVYRYHKA	ULK2	981	Q8IYT8
YEIFETSHGKVYIVM	TSSK1B	76	Q9BXA7
GEVAFGLYMFEIYRK	XKR3	46	Q5GH77
GLYMFEIYRKANDTF	XKR3	51	Q5GH77
ETGKLIMLVNEFYYG	ZNF280C	286	Q8ND82
SLEQYLMEGSYNKVF	PSMD8	231	P48556
YKHVMRGNYETLVSL	ZNF746	121	Q6NUN9
SNVRKTGSYIYEEFM	PPIP5K2	226	O43314
YGLMKYIGEVVRDNT	TRPM8	186	Q7Z2W7
MGLTKQYLRYVASAV	WDR3	1	Q9UNX4
RKLVEYFQQSAVAMY	ZBED1	316	O96006
QVYGDETFKRIYQKM	ZNF831	621	Q5JPB2
YYMALIERGTAKLQA	THOC5	551	Q13769
AMGYRFYVRQAEKVI	THSD4	351	Q6ZMP0
QFYAVLMGKRSENVY	TSNAXIP1	456	Q2TAA8
GEAASALYMVRIYRK	XKRX	46	Q6PP77
IMKRISEYAADIFYS	USP48	526	Q86UV5
FMLQREYVKANDAYL	PRPF18	256	Q99633
YVAFLVYLDLMESKS	TSEN15	61	Q8WW01
ELYKHVMRGNYETLV	ZNF783	166	Q6ZMS7
QEGYFSQMIISYEKI	ZNF283	171	Q8N7M2
QSMGVLVAAYILYFK	SLC30A2	181	Q9BRI3
VFIRYDNMTFEGEFK	MORN4	76	Q8NDC4
IFATMIYYAERIGAD	KCNC3	461	Q14003
KIYEEQNRGIYMFRI	KMT2D	5441	O14686
EVRGAEIEYAMAYSK	MYDGF	111	Q969H8
YSRYGILMTKQELSF	MYO5C	696	Q9NQX4
AVFDLMEGKSYVFRV	MYOM2	571	P54296
IYFLEERMQQKYEAS	PDE4DIP	26	Q5VU43
FIYDAAVLNYMAGKD	GRIN2C	726	Q14957
FIYDAAVLNYMARKD	GRIN2D	756	O15399